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1.1. The pelota gene  
 
The murine pelota (Pelo) gene is located on chromose 13. It consists of three 
exons (300, 729 and 598 bp long), but protein coding sequences are found only in two of 
them  - start codon (ATG) and termination codon (TGA) are situated in second and third 
exon, respectively. Murine Pelo cDNA in comparison t  that of Drosophila, has a 394 bp 
shorter 3’UTR (untranslated region), supposedly due to deletion in mammalian cDNA or 
insertion in fruit fly cDNA. This fact can be of great importance for gene functionality in 
mammals (Shamsadin et al., 2002). The amino acid sequence (385 residues) shares 70% 
homology with Drosophila Pelo and 36% with yeast Dom34 (Shamsadin et al., 2002).  
Pelo gene has been identified in Drosophila melanogaster (Castrillon  et al., 1993) 
and successive studies have revealed its broad expression in diverse species from 
archaebacteria to human  (Lalo et al., 1994; Bult et al., 1996; Ragan et al., 1996; Shamsadin 
et al., 2000, 2002). Similarity in protein structure between various organisms indicates that it 
is highly conserved during evolution (Fig.1). The fact that the phenotype of a null dom34 
(pelota homologue) mutant in yeast has been rescued by expression of Drosophila pelota 
(Davis and Engebrecht, 1998) is additional evidence for evolutionary conservation of the 
gene. 
 Structural analysis of pelota protein has revealed, that it consists of three conserved 
domains (Fig.1B, Fig. 2). Two of them (central and C-terminal ones) are related to domains 
composing eRF1 (an eukaryotic release factor 1), which is involved in termination step of 
protein synthesis (Frolova et al., 1994; Eurwilaichitr et al., 1999). Therefore, pelota was 
originally classified to eRF family, but in the course of time certain differences between Pelo 
and eRF proteins were brought to light. In contrary to central domain of eRF1, Pelo lacks 
universal GGQ (glycine-glycine-glutamine) sequence motif (Lee et al., 2007) enabling 
recognition of a stop codon at the A site of the ribosome and stimulation of peptidyl-tRNA 
bond hydrolysis (Song et al., 2000). Instead, the central domain of Pelo contains a strictly 
conserved tripeptide PGF (proline-glycine-phenylalanine) which strongly influences 
endoribonuclease function (Passos et al., 2009) and may be responsible for interaction with 
ribosomes (Lee et al., 2007). This sequence discrepancy suggests some functional 





Figure 1. A phylogenetic tree of Pelota amino acid sequences (A) and alignment of 
domain structures (B) of various species. 
The tree (A) originates from the TreeFam database. Blue, pink and yellow boxes in panel B 
represent Pfam domains (N-terminal, central and C-terminal, respectively); lines stand for 
regions not belonging to domains. Light-coloured lines are equivalents of mismatched 





Moreover, Pelo N-terminal domain markedly differs from eRF1 (Song et al., 2000; Lee et al., 
2007; Graille et al., 2008). It contains Sm-fold struc ure which serves either to recognize 
mRNA stem loops or to recruit mRNA decay machinery (Wilusz & Wilusz, 2005; Tritschler 
et al., 2007). Nonetheless, the way of RNA recognitio  probably differs from one used by 
Sm-fold-containing proteins, because the Sm structue of Dom34 lacks two motifs involved 
in RNA binding (Graille et al. 2008). It has been found in yeast and Thermoplasma 
acidophilum that Pelo N-terminal domain exhibits endonuclease ctivity dependent on 
divalent metal ion what has unvailed a first known Sm-containing domain with catalytic 
features (Lee et al., 2007). Furthermore, there is a putative leucine zipper motif in C-terminal 
domain that participates in interactions with other proteins (Busch and Sassone-Corsi, 1990). 
Shamsadin et al. (2002) have disclosed putative phosphorylation sites along the whole 
sequence by screening of the PROSITE protein motif library, such as motifs for protein 
kinase C, casein kinase II and tyrosine kinase. Besides, they have detected two N-
glycosylation and three N-myristoylation sites. It is unknown till now which of the sites play 
a role in protein functionality (Fig.2). 
However, Pelo and eRF1 share some similarities. Graille et al. (2008) have compared 
eRF1 and S. cerevisiae Dom34 C-terminal domains which are suggested to interact with 
eRF3 (an eukaryotic release factor 3) and Hbs1 (Hsp70 subfamily B suppresor 1, yeast eRF3 
homologue), respectively. Both interaction partners belong to the GTPase family and are 
responsible for recognition of stop codon and enhancing of polypeptide chain release (Salas-
Marco and Bedwell, 2004). Their study has revealed striking similarities of protein structural 
motifs being crucial for the interaction. Moreover, they have demonstrated that Dom34 
enhances GTP binding to Hbs1, what is neccessary for peptidyl-tRNA hydrolysis upon GTP 
hydrolysis. The feature is convergent to eRF1 impact (Graille et al., 2008). 
Pelota protein is localised in the cytoplasm, but it has been found to contain also a 
putative nuclear localization signal (NLS) at the N-terminus which is conserved from 
Drosophila to human (Eberhart and Wasserman, 1995; Davis and E gebrecht, 1998; 
Shamsadin et al., 2000; 2002). Nevertheless, generation of pelota mutant version in 
Drosophila, where NLS was disrupted, did not lead to loss of Pelo function.  Cytoplasmatic 
distribution of the protein was observed as it was shown in controls. The finding indicates 
that Pelo is located in the cytoplasm and the putative nuclear motif is meaningless for Pelota 






Figure 2. Scheme of PELO protein domains and putative posttranslational modifications 
N-terminal domain containing amino acid range from 1 to 131 (marked in blue); a putative 
nuclear localization signal (NLS) was found in central domain ranging from 136 to 268 aa 
(marked in pink) contains a conserved PGF motif (210- 2 aa); C-terminal domain  from 
271 to 370 aa (marked in yellow) contains leucine zipper motif at the end. P in green – 
protein kinase C phosphorylation sites (aa: 38-40, 3-45, 58-60,342-344); P in red – casein 
kinase II phosphorylation sites (aa: 176-179, 374-377, 380-383, 381-384, 382-385); P in 
green and red – phosphorylation sites common for prtein kinase C and casein kinase II (aa: 
252-255, 335-338); P in orange – tyrosine kinase phos orylation site (276-282 aa); G in 
dark green – N-glycosylation sites (aa: 174-177, 236- 9); M in grey – N-myristoylation 
sites (aa: 54-59, 97-102, 357-362). 
 
1.2. The function of pelota gene in Saccharomyces cerevisiae and Drosophila 
melanogaster 
 
Drosophila pelota null mutants exhibit spermatogenesis arrest. The initial generation 
of spermatogonia and four rounds of mitotic division producing spermatocytes are 
unaffected, but then the cells are arrested in premeiotic G2 phase and meiotic divisions never 
occured. In such accumulated spermatocytes some proc sses were observed to be disrupted, 
such as spindle formation and nuclear envelope breakdown (Castrillon et al., 1993). 
Nonetheless, germ cell development continued and resulted in 4N spermatids possessing 
head and tail structures. This indicates that Pelo protein does not influence spermiogenesis, 
but is required for G2/M transition during meiotic division. However, the role of Pelo is not 
restricted to meiosis – it also plays a role in fly eye development what suggests that Pelo is 
also functionally important in somatic growth (Ebenhart and Wasserman, 1995).  
The detailed study of fruit fly ovary has shown that Pelota participates in germ stem 
cell (GSC) maintenance. In Drosophila, self-renewal of the germline is controlled by BMP 
(bone morphogenetic protein) signal which represses a Bam-dependent differentiation 
pathway. Xi et al. (2005) demonstrated that loss of Pelo leads to rapid differentiation of 
GSCs and loss of germline. Furthermore, they detectd that BMP signal is downregulated in 
mutant GSCs, but it has no influence on expression of bam – the gene that is necessary and 
sufficient for the progression of oogenesis (Ohlstein and McKearin, 1997). To confirm the 




still observed. It indicates that Pelo represses a Bam-independent differentiation pathway. In 
accordance with these findings, overexpression of pelota did not result in downregulation of 
Bam and had no effect on GSC maintenance and differentiation (Xi et al., 2005). 
Analysis of dom34, a pelota ortholog in Sacharomyces cerevisiae,  revealed that its 
null mutant fails to segregate chromosomes properly and produces less amount of spores in 
comparison to wild type yeast owing to lack of efficient G1 phase progression. It was 
suggested that bulk protein translation is impaired, so the key proteins for the phase of cell 
cycle are not translated (Davis and Engebrecht, 1998). Further studies have shown that 
Dom34 protein indeed is involved in translation process. Namely, it recognizes stalled 
ribosomes and cleaves mRNA in an endonucleolytic way in conjunction with Hbs1p, a 
member of the GTPase family. At present it is unclear whether it is  a mRNA-specific or 
only a structure-specific process, but it is assigned to so called No-Go decay pathway. This 
pathway  degrades mRNA, which cannot be translated du  to stalled ribosomes on it (Doma 
and Parker, 2006; Lee et al., 2007). 
 
1.3. The phenotype of Pelota knockout mice 
 
Pelota has been also characterized in human and mouse. It has been found that mouse 
pelota expression starts early in embryonic development and is maintained in all adult tissues 
including all testicular developmental stages (Shamsadin et al., 2000; 2002).  
To examine the function of PELO in mammals, the gene was disrupted by 
homologous recombination (Adham et al., 2003). Heterozygous mice did not exhibit 
apparent developmental malfunctions what proves that a single allele of the gene is sufficient 
for normal growth. However, PELO turned out to be crucial for proper embryogenesis due to 
fetal lethality of Pelo-/- animals. To estimate the time point for their death, embryos of 
different age were collected and genotyped. It was found that implantation is not affected in 
pelota-deficient embryos – the mean number of dissected E6.5- or E7.5-deciduae from 
Pelo+/- intercrosses was similar to those received from wild-type crosses. The critical stage 
when embryos died was E7.5. The morphology of mutant embryos was abnormal and the 
embryos were reduced in size. Although all embryonic germ layers (ectoderm, mesoderm 
and endoderm) could be found, the extraembryonic region was substantially diminished. It 
was suggested that growth impairment was owing to defect in mitotic division, but not in 




(E3.5) were isolated and cultured in vitro. Pelo-/- blastocysts were able to attach to the dish 
and to hatch from zona pellucida. They began to grow, but failed to expand and died within 
4 days in the  culture, whereas trophoblast cells rmained alive and continued growing. It 
was demonstrated that only the cells mitotically active (i.e. ICM) are affected, but those 
which do not divide - survive. This can be related to former findings in Drosophila and yeast 
that Pelo influences cell cycle regulation (Eberhart nd Wasserman, 1995; Davis and 
Engebrecht, 1998). It was also shown in yeast that pelota deficiency leads to meiosis arrest 
and subsequent production of 4N spermatids, what suggests failure in chromosome 
segregation. An examination of cellular DNA content of murine Pelo-/- cells showed 



























1.4. Aims of the study 
 
Comparing up-to-date findings regarding Pelota structure and function in Drosophila 
and yeast versus mammals, some questions arise.  
Molecular mechanism of murine PELO function has not been demonstrated yet. The 
best way to study it, is a system based on in vitro cultures, where pelota is knocked out. It 
would be possible to investigate the basis of a putative proliferation defect of pelota-
deficient cells. It would also facilitate creating more comprehensive system to discover the  
pathway/mechanism, in which pelota is involved.  
As it was impossible to establish an embryonic stem c ll line from Pelo-/- blastocysts, 
we generated conditional knockout mouse. It enabled us to generate pelota-deficient ESC 
lines, where we could study whether PELO controls the maintanence of pluripotency and the 
differentiation processes. 
Moreover, a conditional knockout mouse model can be used to study the 
consequences of PELO depletion in living animal. Due to the fact that spermatogenesis is a 
process where differentiation of pluripotent cells occurs in very apparent way during the 
whole life span, the conditional knockout mouse is a uitable model for studies of cell 
transformation from pluripotent up to differentiated state. Therefore, we generated testis-
specific conditional knockout mice and analyzed avail ble (Buyandelger, 2006) transgenic 
mice with testis-specific pelota overexpression. 
Finally, to clearly demonstrate that the phenotype obtained in Pelo-/- mice  
specifically results from pelota deletion, we bred transgenic mice with ubiquitous 
overexpression of pelota gene together with classicl knockout mice. The aim was to show 
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1 kb DNA Ladder      Invitrogen, Karlsruhe 
100 bp DNA Ladder     Invitrogen, Karlsruhe 
Acetic acid       Merck, Darmstadt 
Agar        Difco, Detroit, USA 
Agarose       Invitrogen, Karlsruhe 
Ammonium acetate      Fluka, Neu Ulm 
Ammonium persulfate     Sigma, Deisenhofen 
Ampicillin       Sigma, Deisenhofen 
Ampuwa       Fresenius, Bad Homburg 
Aprotinin       Sigma, Deisenhofen 
Aqua Poly/Mount      Polysciences, Inc, USA 
Bacto-tryptone      Difco, Detroit, USA 
Bacto-Yeast-Extract      Difco, Detroit, USA 
Blocking powder      Boehringer, Mannheim 
BSA        Biomol, Hamburg 
Cell culture media      PAN-Systems, Nürnberg 
Chemiluminescent Substrate     Pierce, Rockford, IL 
Chloroform       Baker, Deventer, NL 
Coomassie Blue G-250     Sigma, Deisenhofen 
Diethyl pyrocarbonate (DEPC)    Sigma, Deisenhofen 
Dimethyl sulfoxid (DMSO)     Merck, Darmstadt 
Dithiothreitol       Sigma, Deisenhofen 
dNTPs       Invitrogen, Karlsruhe 
EDTA       ICN Biomedicals, Eschwege 
EGTA       Applichem, Darmstadt 
Ethanol       Baker, Deventer, NL 
Ethidium bromide      Sigma, Deisenhofen 
Eukitt-quick hardening mounting medium   Fluka, Neu Ulm 
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FBS        Invitrogen, Karlsruhe 
Ficoll 400       Amersham Pharmalia, Freiburg 
Formaldehyde      Invitrogen, Karlsruhe 
Formamide       Fluka, Neu Ulm 
Glutaraldehyde      Sigma, Deisenhofen 
Glycerol       Invitrogen, Karlsruhe 
Glycine       Biomol, Hamburg 
Goat serum       PAN-Systems, Nürnberg 
HCl        Merck, Darmstadt 
H2O2        Merck, Darmstadt 
HEPES       Merck, Darmstadt 
4-Hydroxytamoxifen      Sigma, Deisenhofen 
Horse serum       PAN-Systems, Nürnberg 
IPTG        Biomol, Hamburg 
Isopropanol       Merck, Darmstadt 
KCl        Merck, Darmstadt 
KH2PO4       Merck, Darmstadt 
Lambda DNA      Roche, Penzberg 
Leupeptin       Sigma, Deisenhofen 
Lipofectamine 2000      TM Invitrogen, Karlsruhe 
Methanol       Merck, Darmstadt 
2-Mercaptoethanol      Serva, Heidelberg 
MgCl2       Merck, Darmstadt 
Milk powder       Roth, Karlsruhe 
NaCl        Merck, Darmstadt 
Na2HPO4       Merck, Darmstadt 
NaH2PO4       Merck, Darmstadt 
NaHCO3       Merck, Darmstadt 
NaN3        Merck, Darmstadt 
NaOH        Merck, Darmstadt 
Nonidet P40       Fluka, Neu Ulm 
NuPAGE Novex Bis-Tris 4-12% Gel   Invitrogen, Karlsruhe 
NuPAGE MOPS/MES SDS running buffer   Invitrogen, Karlsruhe 
NuPAGE SDS sample buffer    Invitrogen, Karlsruhe 
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Orange G       Sigma, Deisenhofen 
OptiMEM I       Invitrogen, Karlsruhe 
Paraformaldehyde      Merck, Darmstadt 
PBS        PAN-Systems, Nürnberg 
Penicillin/Streptomycin     PAN-Systems, Nürnberg 
Peptone       Roth, Karlsruhe 
Phalloidin       Sigma, Deisenhofen 
Phenol       Biomol, Hamburg 
Phosphoric acid      Merck, Darmstadt 
Picric acid       Fulka, Neu Ulm 
Proteinase K       Roche, Penzberg 
Protein marker      Biorad, Sigma 
[32P]-dCTP       Amersham Pharmalia, Braunschweig 
RediprimeTM II      Amersham Pharmacia, Freiburg 
RNase A       Qiagen, Hilden 
RNase away       Biomol, Hamburg 
RNase Inhibitor      Roche, Penzberg 
RNA length standard      Invitrogen, Karlsruhe 
Salmon sperm DNA      Sigma, Deisenhofen 
SDS        Serva, Heidelberg 
SeeBlue Plus2 Pre-Stained Standard   Invitrogen, Karlsruhe 
Select Peptone      Gibco/BRL, Eggenstein 
S.O.C Medium      Invitrogen, Karlsruhe 
Sodium acetate      Merck, Darmstadt 
Sodium citrate      Merck, Darmstadt 
Sun flower oil      Sigma, Deisenhofen 
SuperScript II      Invitrogen, Karlsruhe 
T4 DNA ligase      Promega, Mannheim 
Tamoxifen       Sigma, Deisenhofen 
TRI reagent       Sigma, Deisenhofen 
Tris base       Sigma, Deisenhofen 
Triton X-100       Serva, Heidelberg 
Trypsin       PAN-Systems, Nürnberg 
Tween-20       Sigma, Deisenhofen 
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Vectashield (DAPI)      Vector, Burlingame 
X-Gal        Biomol, Hamburg 
Xylene       Merck, Darmstadt 
Yeast extract       Roth, Karlsruhe 
 
2.1.2 Solutions, buffers and media 
 
All standard buffers and solutions were prepared according to Sambrook et al. (1989). 
 
Annealing buffer (10x)     100 mM TrisHCl pH 7.5 
        1 M NaCl 
        10 mM EDTA 
 
Denaturation solution      1.5 M NaCl 
0.5 M NaOH 
 
Depurination solution      250 mM HCl 
 
E-buffer (10x)       300 mM NaH2PO4 
50 mM EDTA 
 
Bouin’s solution       15 volume of Picric acid (inH2O) 
5 volumes 37% Formaldehyde 
1 volume Acetic acid 
 
Ligation buffer (10x)       600 mM Tris/HCl (pH 7.5) 
80 mM MgCl2 
100 mM DTT 
 
Loading buffer        15% Ficoll 400 
10 mM EDTA (pH 8) 
0,25% Orange G 
1% Glycerol 
 
MATERIALS AND METHODS 
 12 
Lysis buffer I        50 mM Tris/HCl (pH 8.0) 
100 mM EDTA 
0.5% SDS 
 
Lysis buffer II       100 mM Tris/HCl (pH 8.0) 
5 mM EDTA 
200 mM NaCl 
0.2% SDS  
100 µg/ml Proteinase K 
 
Lysis buffer A       50 mM Tris/HCl pH 7.0 
        100 mM NaCl 
        5 mM MgCl2 
        2% Triton X-100 
2% SDS 
1 mM PMSF 
1 mM aprotinin 
1 mM leupeptin 
1 Protease inhibitor cocktail 
tablet/10ml buffer 
 
Neutralisation solution      1.5 M NaCl 
1 M Tris/HCl (pH 7.0) 
 
SSC (20x)        3 M NaCl 
0.3 M sodium citrate (pH 7.0) 
 
TBE buffer (5x)      450 mM Tris base 
450 mM Boric acid 
20 mM EDTA (pH 8) 
 
TE buffer        10 mM Tris/HCl (pH 8.0) 
1 mM EDTA 
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2.1.3 Laboratory materials 
 
The laboratory materials, which are not listed here, w re bought from Schütt and 
Krannich (Göttingen). 
 
Cell culture flask       Greiner, Nürtingen 
Culture slides        BD Falcon, Heidelberg 
Disposable filter Minisart NMI     Sartorius, Göttingen 
Filter paper 0858       Schleicher and Schüll, Dassel 
Hybond C        Amersham, Braunschweig 
Hybond N        Amersham, Braunschweig 
HPTLC Aluminum folio      Merck, Darmstadt 
Microcentrifuge tubes      Eppendorf, Hamburg 
Petri dishes        Greiner, Nürtingen 
Pipette tips        Eppendorf, Hamburg 
RotiPlast paraffin       Roth, Karlsruhe 
Transfection flasks       Lab-Tek/Nalge, Nunc, IL, USA 
Superfrost slides       Menzel, Gläser 
Whatman blotting paper      Schleicher and Schüll, Dassel 
(GB 002, GB 003 and GB 004) 
X-ray films        Amersham, Braunschweig 
 
2.1.4 Sterilisation of solutions and equipments 
 
All solutions that are not heat sensitive were sterilis d at 121°C, 105 Pa for 60 min in 
an autoclave (Webeco, Bad Schwartau). Heat sensitive solutions were filtered through a 
disposable sterile filter (0.2 to 0.45 µm pore size). Plastic wares were autoclaved as above. 
Glasswares were sterilised overnight in an oven at 220°C. 
 
2.1.5 Media, antibiotics and agar-plates 
 
2.1.5.1 Media for bacteria 
 
LB Medium (pH 7.5)      1% Bacto-trypton 
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0.5% Yeast extracts 
1% NaCl 
 
LB-Agar        1% Bacto-trypton 
0.5% Yeast extracts 
1% NaCl 
1.5% Agar 
The LB medium was prepared with distilled water, autoclaved and stored at 4°C. 
 
2.1.5.2 Media for cell and embryo culture 
 
M2 and M16 media were purchased from Sigma (Deisenhof ) and were used for 
washing and cultivation of mouse preimplantation embryos. 
Embryonic stem (ES) cell medium:  DULBECCO´s Modified Eagles Media (DMEM) 
1 mM Non essential amino acids 
1 mM Sodium pyruvate 
10 µM ß-Mercaptoethanol 
2 mM L-Glutamine 
20% FCS 
1000 U/ml Recombinant leukaemia inhibitory 
factor (LIF) 
 
Fibroblast cell medium (MEFs):  DULBECCO´s Modified Eagles Media (DMEM) 




For long time storage of the cells in liquid nitrogen, the following freezing medium was 
used: 
Freezing medium:     20% FCS 
10% DMSO in DMEM 
 
KO medium:     Knockout DMEM optimized for ES cells (Gibco) 
      20% knockout supplement  
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1 mM Non essential amino acids 
1 mM Sodium pyruvate 
10 µM ß-Mercaptoethanol 
2 mM L-Glutamine 
20% FCS 
1000 U/ml Recombinant leukaemia inhibitory 
factor (LIF) 
 
Selective medium:    Embryonic stem (ES) cell medium 
      400 µg/ml G418  




Stock solutions were prepared for the antibiotics. They were filtered through sterile 
disposable filters and stored at –20°C. When antibiotics were needed, in each case, they 
were added after the autoclaved medium has cooled dwn to a temperature lower than 55°C. 
Antibiotics   Stock solution     Working solution 
Ampicillin   50 mg/ml      50 µg/ml 
Kanamycin   25 mg/ml      50 µg/ml 
 
2.1.5.4 IPTG/X-Gal plate 
 
LB-agar with 50 µg/ml ampicillin, 100 µM IPTG and 0.4% X-Gal was poured into  
Petri dishes. The dishes were stored at 4°C. 
 
2.1.6 Bacterial strains 
 
E. coli DH5α       K-12 strain,F- Φ80d lacZ∆M15 endA1 
recA1 hsdR17 (rk-, mk+) sup E44 thi-1 
d- gyrA96 (lacZYA-arg) 
(Invitrogen, Karlsruhe) 
E. coli BL21 (DE3)   B strain, F- ompT hsdSB(rB-mB-) gal, 
Dcm (Novagen, Darmstadt) 




pBluesript SK (+/-)      (Stratagene, La Jolla, USA) 
pGEMTeasy       (Promega, Wisconsin, USA) 
 
2.1.8 Synthetic oligonucleotides 
 
The synthetic oligonucleotide primers used in this study were obtained from 
OPERON and dissolved in dH2O (Ampuwa) to a final concentration of 100 pmol/µl. 
Name       Sequence 
3’regionA_F     5’ CATTATCCACTGCCCACATTC 3’ 
3’region_R     5’ TAGAACTGGCCTTCTCGCAC 3’ 
cKO_3’ext_F     5’ GCGAATACGTCAGCAGAAG 3’ 
cKO_3’ext_R     5’ GAGTCACAAGTGGGCAATG 3’ 
Cre_R      5’ AGTGAAACAGCATTGCTGTCA 3’ 
EIIa-CreF      5’ CCAGGCTAAGTGCCTTCTCTACA 3’ 
EIIa-CreR      5’ AATGCTTCTGTCCGTTTGCCGGT 3’ 
EvaL1_F     5’ TCTCTTGTTCTAAGATGTGCTGTG 3’ 
EvaL1_GenomeWalk_F2   5’ ACCCTGGCGTTACCCAACTTAATCGC 3’ 
EvaL1_R     5’ AAAGGGGCTCGATTAGATGAACT 3’ 
m18S_F     5’ CGCAAATTACCCACTCCCG 3’ 
m18S_R     5’ TTCCAATTACAGGGCCTCGAA 3’ 
mc-Kit_F     5’ GCCACGTCTCAGCCATCTG 3’ 
mc-Kit_R     5’ GTCGGGATCAATGCACGTCA 3’ 
mDAZL_F     5’ CTCCACCTTCGAGGTTTTACC 3’ 
mDAZL_R     5’ GTGATTTCGGTTTCATCCATC 3’ 
mPelo.RT-PCR-F2     5’ ATCCAGCGCCACATAAACTT 3’ 
mPelo.RT-PCR-R2     5’ CTCTCCACCTGCTTGAGTCC 3’ 
mPlzf_F     5’ CTCCGTAAGCGTCCCCTCTGC 3’ 
mPlzf_R     5’ GGTGCAGGCTAGCACCGTCC 3’ 
mSDHA_F     5’ GCTTGCGAGCTGCATTTGG 3’ 
mSDHA_R     5’ CATCTCCAGTTGTTCTCTTCCA 3’ 
mSox3_F     5’CACATGAAGGAGTAGTACCCGGACTA 3’ 
mSox_R     5’ TGAGCAGCGTCTTGGTCTTG 3’ 
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mStra8_F     5’ CTGTTGCCGGACCTCATG 3’ 
mStra8_R     5’ TCACTTCATGTGCAGAGATGATG 3’ 
mVASA_F     5’ GAGAAGTGGGTTTCCTTCTGG 3’ 
mVASA_R     5’ GAAAACCCTCTGCTTCGAGTC 3’ 
Pelo_F11      5’ TGAGCCCAGACTGTACGTGAC 3’ 
Pelo_R14     5’ AACGTCAAAGGAGGCGGTCAG 3’ 
Pelota3’F2     5’ GGTATCATGGCCTCTATTCAG 3’ 
Pelota3’R2     5’ GCACAGACATGACCAATACG 3’ 
PGK_cKO_R1    5’ CCACTTGTGTAGCGCCAAGTG 3’ 
RosaCreER-F     5’ ACCAGCCAGCTATCAACTC 3’ 
RosaCreER-R   5’TATACGCGTGCTAGCGAAGATCTCCATCTTCCAGCAG 3’ 
Stra8_F     5’ GCGCTCCTAGTGTGCCAGTTTGAT 3’ 
Trans.pEF-F      5’ CATTCTCAAGCCTCAGACAGTG 3’ 
Trans.pUB-F      5’ TCAGTGTTAGACTAGTAAATTG 3’ 
Trans.hPelo-R1     5’ GAGGACTCTGTCTGTACCTTG 3’ 
 
2.1.9 Mouse strains 
 
Strains C57BL/6J, 129/Sv, CD-1 and NMRI were initially ordered from Charles 
River Laboratories, Wilmington, USA, and kept in Animal Facility of Institute of Human 
Genetics, Göttingen. ROSA26CreERT (Berns A, Netherlands) and EIIaCre (Lakso et al., 





Goat anti-mouse IgG alkaline phosphatase conjugate  Sigma, Deisenhofen 
Goat anti-rabbit IgG alkaline phosphatase conjugate   Sigma, Deisenhofen 
Goat anti-rabbit GFP antiserum      Sigma, Deisenhofen 
Rabbit anti-mouse IgG Cy3 conjugate     Sigma, Deisenhofen 
Goat anti-rabbit IgG FITC conjugate     Sigma, Deisenhofen 
Rabbit anti-mouse IgG FITC conjugate     Sigma, Deisenhofen  
Mouse monoclonal anti β-tubulin      Sigma, Deisenhofen 
Goat anti-rabbit IgG horse radish preoxidase conjugate   Sigma, Deisenhofen 
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Rabbit anti-mouse IgG horse radish preoxidase conjugate   Sigma, Deisenhofen 
Rabbit anti Pelota polyclonal antibody     Institute of Human Genetics 
mouse anti GCNA1 monoclonal antibody   G. Enders, University of Kansas, USA 
Rabbit anti HSP110 polyclonal antibody    Sigma, Steinheim 
Rabbit anti Apg1 polyclonal antibody   Santa Cruz Biotechnology, Heidelberg 
Rabbit anti Apg2 polyclonal antibody   Santa Cruz Biotechnology, Heidelberg 




Antarctic Phosphatase     (BioLabs, Frankfurt am Mein) 
FideliTag DNA Polymerase     (USB, Staufen) 
Immolase DNA Polymerase      (Bioline, Luckenwalde) 
Klenow Fragment       (Invitrogen, Karlsruhe) 
Proteinase K        (Sigma, Deisenhofen) 
Platinum Taq polymerase      (Invitrogen, Karlsruhe) 
Restriction enzymes (with supplied buffers)   (Invitrogen, Karlsruhe) 
RNase A        (Qiagen, Hilden) 
RNase H        (Invitrogen, Karlsruhe) 
RNase inhibitor       (Invitrogen, Karlsruhe) 
Superscript-II        (Invitrogen, Karlsruhe) 
Taq polymerase       (Invitrogen, Karlsruhe) 
T4 DNA ligase       (Promega, Mannheim) 
Trypsin        (Invitrogen, Karlsruhe) 
 
2.1.12 Radioactive substances 
 




AP Kit (86C-1 KT)       (Sigma, Deisenhofen) 
Endo Free Plasmid Maxi Kit     (Qiagen, Hilden) 
GenomeWalker Universal Kit    (Clontech) 
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Labelling System       (Qiagen, Hilden) 
Megaprime DNA Labeling Kit     (Amersham Pharmacia, Freiburg) 
Midi Plasmid Kit       (Invitrogen, Karlsruhe) 
Mini Plasmid Kit       (Qiagen, Hilden) 
PCR Purification Kit       (Qiagen, Hilden) 
QIAquick Gel Extraction Kit     (Qiagen, Hilden) 
RNAeasy Kit        (Qiagen, Hilden) 




Autoclave        (Webeco, Bad Schwartau) 
Centrifuge 5415D       (Eppendorf, Hamburg) 
Centrifuge 5417R       (Eppendorf, Hamburg) 
Biophotometer       (Eppendorf, Hamburg) 
DNA Sequencer Modell Megabace 1000    (Amersham, Freibu g) 
Microscope BX60       (Olympus, München) 
GeneAmp PCR System 9600     (Perkin Elmer, Berlin)  
Histocentre 2 embedding machine     (Shandon, Frankfurt aM.) 
Microtiterplate-Photometer      (BioRad laboratories, München) 
Molecular Imager FX      (BioRad laboratories, München) 
Phosphoimager Screen      (BioRad laboratories, Münche ) 
Semi-Dry-Blot Fast Blot      (Biometra, Göttingen) 
Spectrophotometer Ultraspec 3000     (Amersham, Freiburg) 
SpeedVac concentrator SVC 100H     (Schütt, Göttingen) 
Thermomixer 5436       (Eppendorf, Hamburg) 
TurboblotterTM       (Schleicher & Schüll, Dassel) 











2.2.1 Isolation of nucleic acids 
 
2.2.1.1 Isolation of plasmid DNA (Sambrook et al., 1989) 
 
Small-scale isolation of plasmid DNA (Birnboim and Doly, 1979) 
A single bacterial colony was inoculated into 5 ml LB medium, containing an 
appropriate antibiotic, and incubated at 37°C for 12-16 hours with a shaking speed of 160 
rpm. 0.2 ml of this  culture was used for glycerol stock and rest of it was centrifuged at 4000 
x g for 10 min. The pellet was resuspended in 100 µl of resuspension solution P1 
(Invitrogen). The bacterial cells were lysed with 200 µl of lysis solution P2 (Invitrogen), 
incubated at RT for 5 min and then neutralised with 150 µl of neutralisation solution P3 
(Invitrogen). The precipitated solution was incubated at RT for 5 min and centrifuged at 
13000 x g at RT. The supernatant was transferred into a new tube, where 1 ml of 100% 
ethanol was added to precipitate the DNA. Then it was incubated for 30 min at RT, 
centrifuged at full speed for 20 min, and finally the pellet was washed with 350 µl of 70% 
ethanol and after air-drying dissolved in 30 µl of dH2O. 
P1: 50 mM Tris/HCl, pH 8.0; 10 mM EDTA; 100 µg/ ml RNase A 
P2: 200 mM NaOH; 1% SDS 
P3: 3 M Potassium acetate, pH 5.5 
 
 
Large-scale preparation of Endotoxin free plasmid DNA using the  
Qiagen Maxi Kit 
A single clone was inoculated into 5 ml LB medium, containing an appropriate 
antibiotic. The preculture was incubated for 12 hours at 37°C with shaking. Then it was 
diluted 500 times in 100 ml of the same medium and incubated overnight at 37°C with 
shaking. Next day it was centrifuged at 6000 x g for 15 min. The pellet was resuspended in 5 
ml of solution P1 and cells were lysed with P2 and P3 as described above. The precipitated 
solution was centrifuged at 20000 x g for 30 min at 4°C. Meanwhile, the column (Qiagen-
tip), that was provided with the maxi preparation kit, was equilibrated with 10 ml of QBT 
solution. After centrifugation, the lysate was poured into this equilibrated column to allow 
the DNA to bind with the resin present on the bottom f the column. The column was then 
washed twice with 10 ml of solution QC. Finally, the DNA was eluted with 5 ml of QF 
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solution. For precipitation of  the DNA, 3.5 ml of isopropanol was added, mixed thoroughly 
and then centrifuged at 14000 x g for 30 min at 4°C. The obtained pellet was washed with 
70% ethanol and dissolved in 100 µl of TE buffer. 
QBT: 750 mM Sodium chloride; 50 mM MOPS pH 7.0; 15 % Ethanol; 0.5 % Triton X-100 
QC: 1 mM Sodium chloride; 50 mM MOPS pH 7.0; 15 % Ethanol 
QF: 1.25 M Sodium chloride; 50 mM Tris/HCl pH 8.5 
 
2.2.1.2 Isolation of genomic DNA 
 
Isolation of genomic DNA from tissue samples (Laird et al., 1991) 
1 cm of the mouse tail was incubated in 700 µl of lysis buffer I containing 35 µl 
proteinase K (10 µg/µl) at 55°C overnight in Thermomixer 5436. The tissue lysate was 
centrifuged at 14000 x g for 15 min and the supernatant was transferred into a new e-cup. 
Then, DNA was precipitated by adding an equal volume of isopropanol, mixed by inverting 
several times and centrifuged at 14000 x g at RT for 15 min. DNA was washed with 1 ml of 
70% ethanol, dissolved in 50-100 µl of dH2O and incubated at 60°C for 10 min. 
 
Isolation of genomic DNA from cultured cells 
Cells were washed with PBS and incubated overnight in 500 µl of lysis buffer II at 
37oC. Next, equal volume of isopropanol was added, mixed by inverting several times and 
incubated for 10 min at RT. Then, centrifuged for 15 min at maximal speed. After washing 
the pellet with 70% ethanol, the DNA was dissolved in 80 µl of dH2O and incubated at 60
oC 
for 10 min. 
 
2.2.1.3 Isolation of total RNA from tissue samples and cultured cells 
 
Total RNA isolation reagent is an improved version of the single-step method for 
total RNA isolation. The composition of reagent includes phenol and guanidine thiocyanate 
in a mono-phase solution. 100-200 mg of tissue sample was homogenised in 1 ml of TRI 
Reagent by using an e-cup homogeniser. The sample volume did not not exceed 10% of the 
volume of reagent used for the homogenisation. To isolate total RNA from cultured cells, 
350 µl of reagent was added to the Petri dish (6 cm). Cells were homogenised with a rubber 
scraper and the lysate was transferred into a microcentrifuge tube, where it was incubated at 
4°C for 5 min to permit the complete dissociation of nucleoprotein complexes. Then, 0.2 ml 
of chloroform was added, mixed vigorously, and stored at 4°C for 10 min. After 
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centrifugation at 12000 xg for 15 min at 4°C, the upper aqueous phase was transferred into a 
new tube. The RNA was precipitated by adding 0.5 ml of isopropanol. Finally, the pellet 
was washed twice with 75% ethanol and dissolved in 30-80 µl of RNase free water (DEPC-
dH2O). 
 
2.2.2 Determination of nucleic acid concentration 
 
The concentration of nucleic acids was determined spectrophotometrically by 
measuring absorption of the samples at 260 nm. The quality of nucleic acids i.e. 
contamination with salt and protein was estimated by ratio of absorbance 260nm/280 nm. 
The correct value of the ratio is 1,8 for DNA and 2,0 for RNA. 
 
2.2.3 Determination of transgene integration – GenomeWalker Universal Kit 
 
 GenomeWalker Kit helps to find  unknown genomic DNA sequences adjacent to a 
known sequence. First step was to construct pools which consist of adaptor-ligated genomic 
DNA fragments (i.e. libraries). Thereafter, primary PCR was done by using outer adaptor 
primer (AP1) provided in the kit and outer gene-specific primer (EvaL1_GenomeWalk_F1 
for EvaL1 line). Diluted primary PCR mixture was then used as a template for nested PCR 
with a nested adaptor primer (AP2) provided in the kit and nested gene-specific primer 
(EvaL1_GenomeWalk_F2). The obtained result was a major PCR product from at least three 
of four libraries. All fragments were sequenced. The one, which began with a known 
sequence at the 5’ end of EvaL1_GenomeWalk_F2 primer and extended into the unknown 
adjacent genomic DNA, was further cloned, sequenced and compared to mouse genome 
sequence.  
 The procedure was exactly followed according to manuf cturer’s protocol 
(GenomeWalker Universal Kit – User Manual, cat. no. 638904, Clontech). 
 
2.2.4 Gel electrophoresis 
 
Gel electrophoresis is the technique which enables separation of nucleic acids and 
proteins in an electrical field according to their mobility which is directly proportional to 
macromolecule’s charge to mass ratio. 
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2.2.4.1 Agarose gel electrophoresis of DNA 
 
Agarose gels were used to run nucleic acid molecules from as small as 50 bases to 
more than 20 kb, depending on the concentration of the agarose. Usually, 1 g agarose was 
added to 100 ml of 0.5 x TBE buffer and boiled in the microwave to dissolve the agarose, 
then cooled down to about 60°C before adding 3 µl of ethidium bromide (10 mg/ml). This 
1% agarose gel was poured into a horizontal gel chamber. 
 
2.2.4.2 Agarose gel electrophoresis of RNA (Hodge, 1994) 
 
mRNA molecules often have complementary regions that can form secondary structures. 
Therefore, RNA was pre-treated with formaldehyde and formamide in order to denature the 
secondary structure of RNA and it was run on an agarose gel containing formaldehyde. 
1.25g of agarose was added to 100 ml of 1 x E buffer and dissolved by heating in a 
microwave. After cooling it to about 60°C, 25 ml of f rmaldehyde (37%) was added, stirred 
and poured into a vertical gel chamber. RNA samples (10 – 30 µg) were mixed with double 
volume of sample buffer, then denatured at 65oC for 10 min and chilled on ice. After adding 
loading buffer (equal volume to RNA sample), the gel was loaded and run at 70-80V at 4oC 
for 4 – 5 hours. 
Sample buffer/ 1 sample: 2 µl 10x E buffer; 3 µl 37% formaldehyde; 8 µl 40% formamide;  
Loading buffer:  40 µl 1% ethidium bromide in 500 µl standard loading buffer 
 
2.2.4.3 SDS-PAGE gel for separation of proteins 
 
NuPage 4-12% Bis-Tris gel is SDS-PAGE gel with 4-12% percentage gradient what 
allows more efficient separation of proteins. 20.5 µl of whole protein lysate was mixed with 
7.5 µl 4 x NuPage sample buffer and 2 µl 1M DTT. Then, the samples were denatured in 
95oC for 10 min and chilled in ice. The gel electrophoresis was run in 1 x MOPS buffer or 1 
x MES buffer (Invitrogen). As a weight marker, a pre-stained molecular weight standard 
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2.2.5 Purification of DNA fragments from agarose gel 
 
To extract and purify DNA of 70 bp to 10 kb in length from agarose gels, QIAquick 
gel extraction kit (Qiagen) was used. Up to 400 mg agarose can be processed during single 
isolation. 3 volumes of QG buffer were added to an agarose gel piece and then incubated at 
50°C for 10 min. After the gel slice was dissolved, the solution was applied to a QIAquick 
column and centrifuged for 1 min. The flow through was discarded and the column was 
washed with 0.75 ml of PE buffer. After drying, the column was placed into a fresh 
microcentrifuge tube. To elute DNA, 50 µl of dH2O was applied to the centre of the 
QIAquick membrane and the column was centrifuged for 1 min. 
 
2.2.6 Enzymatic modifications of DNA 
 
2.2.6.1 Restriction of DNA 
 
Restriction enzyme digestions were performed by incubating double-stranded DNA 
with a restriction enzyme in amount of max. 1/10 reaction volume in a buffer recommended 
by the supplier, and at the optimal temperature for the specific enzyme. Standard digestions 
included 2-10 U enzyme per 1 µg DNA. Usually incubation time was 1-3 hours at 37°C. For 
genomic DNA digestion, the reaction solution was incubated overnight at 37°C. 
 
2.2.6.2 Ligation of DNA fragments 
 
The cloning of an insert DNA into a vector (digested with appropriate restriction 
enzyme) was carried out in the following ligation reaction mix in total volume of 10 µl: 
• 30 ng vector DNA (digested) 
• 50-100 ng insert DNA (1:3, vector: insert ratio) 
• 1 µl ligation buffer (10x) 
• 1 µl T4 DNA ligase (5 U/µl) 
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2.2.6.3 TA-Cloning (Clark, 1988; Hu, 1993) 
 
Taq polymerase and other DNA polymerases have a terminal transferase activity that 
results in the non-template addition of a single nucleotide to the 3' ends of PCR products. In 
the presence of all 4 dNTPs, dATP is preferentially dded. This terminal transferase activity 
is the basis of the TA-cloning strategy. For cloning of PCR products, a pGEMTeasy vector 
system that has 5‘T overhangs was used. The following substances were mixed: 
• 50 ng of pGEMTeasy vector 
• 150 ng PCR product 
• 1 µl of T4 DNA Ligase buffer (x10) 
• 1 µl of T4 DNA Ligase 




 The removal of 5’ phosphate groups from DNA was done by using of Antarctic 
Phosphatase (BioLabs). Dephosphorylation mixture was prepared as follows: 
1 µg DNA 
2 µl 10x AP buffer 
1 µl 5U Antarctic Phosphatase 
The mixture of 20 µl was then incubated at 37oC for either 15 (for 5’ extension) or 60 min 
(for 3’ extension). Afterwards, the enzyme was inactiv ted for 10 min in 65oC. 
 
2.2.7 Transformation of competent bacteria (Ausubel et al., 1994) 
 
Transformation of bacteria was done by gently mixing 50 µl-aliquot of competent 
bacteria (Invitrogen) with 10 µl of ligation reaction. After incubation for 30 min on ice, 
bacteria were heat-shocked for 45 sec at 37°C and cooled down for 2 min on ice. After 
adding 450-900 µl of S.O.C. medium, the mixture was incubated at 37°C, 400 rpm, for 1 
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2.2.8 Polymerase Chain Reaction (PCR) 
 
In general, the PCR reaction contained the following substances: 
• 10 ng DNA 
• 1 µl forward primer (10 pmol) 
• 1 µl reverse primer (10 pmol) 
• 1 µl 10 mM dNTPs 
• 5 µl 10 x PCR buffer 
• 1.5 µl 50 mM MgCl2 
• 0.5 µl Taq DNA Polymerase (5 U/l) 
• Up to 50 µl dH2O 
The reaction mixture was placed in a 200 µl reaction tube and placed in a thermocycler. 
Thermal cycling was carried out for 35 cycles with denaturation at 95°C for 30 sec, 
annealing at 55-60°C for 30 sec and extension at 72°C for 30 sec. -1 min (depending on the 
product size). 
 
2.2.8.1 Genotyping PCRs 
 
Flox/-/∆ PCR 
Ingredients:      Program: 
H2O    11,6 µl   94
oC – 5 min 
buffer    1,5 µl   94oC – 30 sec. 
MgCl2    0,3 µl   65
oC – 50 sec.  35x 
dNTPs    0,3 µl   72oC – 30 sec. 
Pelo_F11   0,3 µl   72oC – 7 min 
Pelo_R14   0,3 µl    
PGK_cKO_R1   0,3 µl 
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
CreEIIa PCR 
Ingredients:      Program: 
H2O    6,1 µl   94
oC – 5 min 
buffer    1 µl   94oC – 30 sec. 
MgCl2    0,3 µl   67
oC – 40 sec.  30x 
dNTPs    0,2 µl   72oC – 40 sec. 
EllaCre_F   0,6 µl   72oC – 7 min 
EllaCre_R   0,6 µl    
Taq Platinum   0,15 µl 
DNA    0,5 µl 
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Cre PCR (cKO/Stra8 line) 
Ingredients:      Program: 
H2O    20 µl   94
oC – 5 min 
buffer    2,5 µl   94oC – 45 sec. 
MgCl2    0,75 µl   57
oC – 55 sec.   35x 
dNTPs    0,5 µl   72oC – 1 min 20 sec. 
Stra8_F   0,5 µl   72oC – 7 min 
Cre_R    0,5 µl    
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
CreERT PCR 
Ingredients:      Program: 
H2O    6,8 µl   94
oC – 5 min 
buffer    1 µl   94oC – 30 sec. 
MgCl2    0,4 µl   56
oC – 30 sec.  30x 
dNTPs    0,2 µl   72oC – 50 sec. 
RosaCreER_F   0,5 µl   72oC – 7 min 
RosaCreER_R   0,5 µl    
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
EvaL1 PCR 
Ingredients:      Program: 
H2O    18 µl   94
oC – 5 min 
buffer    2,5 µl   94oC – 30 sec. 
MgCl2    1 µl   60
oC – 45 sec.  35x 
dNTPs    0,5 µl   72oC – 30 sec. 
EvaL1_F   1 µl   72oC – 7 min 
EvaL1_R   0,5 µl    
EvaL1_GenomeWalk_F2 0,5 µl
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
AdamL1, AdamL9, EvaL6 
The PCRs were performed according to established protocols for these lines (Buyandelger, 
2006). 
 
2.2.8.2 Generation of Southern probes 
 
5’external probe 
The probe was generated by Buyandelger (2006). 
 
Internal probe (3’probe, 266bp) 
The probe was amplified by PCR as follows: 
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Ingredients:      Program: 
H2O    17,5 µl   94
oC – 5 min 
buffer    2,5 µl   94oC – 30 sec. 
MgCl2    1 µl   60
oC – 50 sec.  35x 
dNTPs    1 µl   72oC – 45 sec. 
Pelota3’_F2   1 µl   72oC – 7 min 
Pelota3’_R2   1 µl    
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
The PCR product was subcloned into pGEMTeasy and sequenced. The 266 bp EcoRI 
fragment was purified and used as a probe for Southern blot. 
 
3’external probe (885bp) 
It was amplified by PCR as follows: 
Ingredients:      Program: 
H2O    19,8 µl   94
oC – 5 min 
buffer    2,5 µl   94oC – 30 sec. 
MgCl2    0,5 µl   58
oC – 30 sec.  35x 
dNTPs    0,5 µl   72oC – 45 sec. 
cKO_3’ext_F   0,5 µl   72oC – 7 min 
cKO_3’ext _R   0,5 µl    
Taq Platinum   0,15 µl 
DNA    0,5 µl 
 
The PCR product was subcloned into pGEMTeasy and sequenced. The 885 bp EcoRI 
fragment was purified and used as a probe for Southern blot. 
 
2.2.8.3 Reverse transcription PCR (RT-PCR) 
 
RT-PCR generates cDNA fragments from RNA templates nd helps to determine the 
expression of genes in specific tissues or in different development stages.  
1-5 µg of total RNA was mixed with 1 µl of oligo (dT)18 primer (10 pmol/µl) in a 
total volume of 12 µl. For denaturation the mixture was heated to 70°C for 10 min and then 
quickly chilled on ice. After a brief centrifugation, the following substances were added to 
the mixture: 
• 4 µl 5 x first strand buffer 
• 2 µl 0.1 M DTT 
• 1 µl 10 mM dNTPs 
• 1 µl RNasin (10 U/µl) 
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The reaction was incubated at 42°C for 2 min. Then, 1 µl of reverse transcriptase 
enzyme (Superscript II, Invitrogen) was added and the mixture was incubated at 42°C for 50 
min for the first strand cDNA synthesis. Next, the reaction was inactivated by heating at 
70°C for 15 min 1 µl of the first strand reaction was used for the PCR reaction. 
 
2.2.8.4 Quantitive Real-Time PCR  
 
DNA was isolated from transgenic mice tails by the m thod described above 
(2.2.1.2.1). Serial dilutions of sample and standard DNA’s were made. Standard DNA (a 
mixture of Founder DNA and two F1 males) was serially diluted to 20, 10, 5, 2.5, 1.25 and 
0.625 ng/µl for the generation of standard curve, while each sample DNA (transgenic mice) 
was diluted to a concentration of 10 ng/µl. Primers were designed to generate amplicons less 
than 200 bp, thus enhancing the efficiency of PCR amplification. Real-Time quantitative 
PCR was performed using QuantiTect SYBR Green PCR Master mix (Quiagen) in an ABI 
Prism 7900HT sequence detection system. Each reaction was run in triplicate and the 
melting curves were analysed to ensure that only a single product was amplified. 18S 
primers were used for the normalisation of each DNA sample. Quantitative real-time PCR 
reactions of DNA specimens and standards were conducte  in a total volume of 10 µl with 5 
µl of 2 x QuantiTect SYBR-Green PCR-Master-Mix, 1 µl of each forward and reverse 
primer in a final concentration of 9 µM and 2.5 µl of DNA.  
 
The following cycling parameters were used: 
2 min 50°C 
15 min 95°C 
15 sec 95°C 
30 sec 60°C        40x 
30 sec 72°C 
15 sec 95°C 
15 sec 60°C melting curve 
15 sec 95°C 
 
Standard curves of the threshold cycle number versus the log number of copies of 
genes were generated for transgenic integration sites and were used to extrapolate the 
number of integration sites of transgene. Quantitative Real-Time PCR results were reported 
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as the number of transgenic allele in comparison to transgenic allele in founder mouse. The 
samples were normalized by reference to 18S gene. 
 
2.2.8.5 Quantitive Real-Time RT-PCR  
 
In general Quantitative Real-Time RT-PCR for mRNAs was performed as for DNA 
(2.2.2.8.3). cDNA synthesis was done according to section 2.2.8.2 with preceding DNAse 
treatment. 5 µl 2x QuantiTect SYBR-Green PCR-Master-Mix, 1 µl Forward Primer (9µM), 
1 µl Reverse Primer (9µM), 0.3µl MgCl2 (50mM) and 1µl of cDNA (in a 1/20 dilution) 
were mixed with RNase free water to a total volume of 10 µl. The following PCR program 
was used: 
2 min 50°C 
15 min 95°C 
15 sec 95°C 
30 sec 55°C        40x 
30 sec 72°C 
15 sec 95°C 
15 sec 60°C melting curve 
15 sec 95°C 
Primer sequences are provided in section 2.1.9. Sdha was used as endogenous 
reference. For standard curves, a mixture of NMRI testes cDNA and cKO/Stra8_Cre testes 
cDNA was used. Selection of the appropriate sample for the standard curve was based on 
preliminary experiments testing detection of expression of each gene by RT-PCR (2.2.8.2). 
Reliability of Real-time PCR data was also assessed in connection with the respective 
dissociation curves.           `  
 
2.2.9 Protein manipulation methods 
 
2.2.9.1 Isolation of total protein lysate 
 
Approximately 100 mg of tissue was homogenised in 200 - 500 µl lysis buffer A. 
Then, the samples were treated with ultrasound on ice 2 x 1 min, centrifuged at 8000 x g for 
20 min at 4oC and the supernatant was aliquoted in several microcentrifuge tubes. The tubes 
were frozen in liquid nitrogen and stored at -80oC.  
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5 x 106 cells/ml were washed with cold phosphate buffered saline (PBS) and 
resuspended in 50 - 200 µl of lysis buffer A. The cells were left on ice for 30 min, treated 
with ultrasound on ice 2 x 30 sec and centrifuged at 24000 x g for 20 min at 4oC. The 
supernatant with protein extract was either used immediately or stored at –80oC for later use. 
 
2.2.9.2 Determination of protein concentration (Bradford, 1976) 
 
To determine the protein concentration, Bio-Rad protein assay was employed. The 
BSA stock solution of 1 mg/ml was diluted in order to obtain standard dilutions in range of 
10 µg/ml to 100 µg/ml. The dye reagent concentrate (Bio-Rad Laboratories GmbH) was 
diluted 1:5 with H2O and 2 µl sample were added. The absorption of the color reaction was 
measured at 595 nm in a spectrophotometer. 
 
2.2.10 Blotting techniques 
 
2.2.10.1 Southern blotting of DNA (Southern, 1975) 
 
After electrophoresis of DNA, the gel was treated with 0.25 M HCl for depurination 
for 20 – 30 min, with denaturation solution for 30 min and neutralisation solution for 45 min. 
The transfer of the DNA to the nitrocellulose membrane was done in a Turbo-Blot apparatus 
(Schleicher & Schuell, Dassel). About 25-28 Whatman filter papers (GB 003) were layered 
on a Stack Tray, followed by 4 Whatman filter papers (GB 002) and 1 Whatman filter paper 
(GB 002) soaked with 20 x SSC. The equilibrated nitrocellulose filter, that was also soaked 
with 20 x SSC, was laid on the top. The agarose gel, treated as described above, was placed 
on the filter and was covered with 3 Whatman filter papers GB 002 soaked with 20 x SSC. 
The buffer tray was filled with 20 x SSC. Finally a wick, which was soaked with 20 x SSC, 
and the wick cover were put on top of the blot. The transfer was carried out for overnight. 
Finally, after disassembling of the blot, the DNA was fixed onto the filter by baking at 80°C 
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2.2.10.2 Northern blotting of RNA 
 
The procedure performed for the transfer of RNA onto a nitrocellulose filter was the 
same as described above (2.2.10.1). However, the gel did not need to be denaturated, but 
was transferred directly onto the filter. 
 
2.2.10.3 Western blotting of protein (Gershoni and Palade, 1982) 
 
After electrophoresis of proteins, the SDS PAGE gel and the PVDF membrane were  
moistened with transfer buffer. Four pieces of filter paper were soaked in transfer buffer and  
placed on the semi dry transfer machine’s lower plate. Then, wet membrane and the gel 
were put, avoiding any air bubbles. Another four soaked Whatman papers were placed on 
the pile to complete the sandwich model. The upper late was placed over this sandwich and 
the transfer was carried out at 3.5 mA/cm2 for 1 hr. 
 After blotting, the gel was stained with Comassie blue overnight at RT in order to 
check the amount of proteins which were not transferred. 
 
2.2.11 “Random Prime” method for generation of 32P labeled DNA (Denhardt, 1966; 
Feinberg and Vogelstein, 1984) 
 
RediprimeTM II Random Prime Labeling System (Amersham Pharmacia) was used 
for labelling of DNA probes. The method depended on the random priming principle 
developed by Feinberg and Vogelstein (1984). The reaction mix contained dATP, dGTP, 
dTTP, Klenow fragment (4-8 U) and random oligodeoxyribonucleotides. Firstly, 25-50 ng 
DNA were denaturated in a total volume of 46 µl at 95oC for 10 min and quickly chilled on 
ice for 5 min. After pipetting the denaturated probe into RediprimeTM II Random Prime 
Labelling System cup, 4 µl of [α-32P] dCTP (3000 Ci/mmol) were added to the reaction 
mixture. The labelling reaction was carried out at 37°C for 45 min. The labelled probe was 
purified from uncorporated [α-32P] dCTP by using illustraTMProbe QuantTM G-50 Micro 
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2.2.12 Non-radioactive dye terminator cycle sequencing 
 
Non-radioactive sequencing was performed with the Dye Terminator Cycle 
Sequencing-Kit (ABI PRISM). The reaction products were analysed with automatic 
sequencing equipment, MegaBase DNA Sequencer. For the sequencing reaction, four 
different dye labelled dideoxy nucleotides were used (Sanger et al., 1977), which, when 
exposed to an argon laser, emit fluorescent light that can be detected and interpreted. 
The reaction was carried out in a total volume of 10 µl containing 1 µg plasmid DNA 
or 100-200 ng purified PCR products, 10 pmol primer and 4 µl reaction mix (contained 
dNTPs, dideoxy dye terminators and Taq DNA polymerase). Elongation and chain 
termination took place during the following program in a thermocycler: 4 min denaturation 
followed by 25 cycles at 95°C, 30 sec; 55°C, 15 sec, annealing; 60°C, 4 min, elongation. 
After the sequencing reaction, the DNA was precipitated with 1/10 volume 3 M sodium 
acetate and 2.5 volume 100% ethanol and washed in 70% ethanol. The pellet was dissolved 
in 4 µl of loading buffer, denaturated at 95°C for 3 min, a d finally loaded on the sequence 
gel. 
 
2.2.13 Hybridisation of nucleic acids (Denhardt, 1966) 
 
A membrane for hybridization was equilibrated in 2 x SSC and transferred to a 
hybridisation bottle. After adding 12 ml of Rapid-hyb buffer (GE Healthcare) and sheared 
denaturated salmon DNA, the membrane was incubated for 2 hours in the hybridisation 
oven at 65°C. Then, the labelled probe was denaturated t 95°C for 10 min, chilled on ice 
for 5 min, and added to the hybridisation solution. The hybridisation was carried out 
overnight in the oven. Next day, the filter was washed for 10 min with 2 x SSC, then with 2 
x SSC containing 0.2% SDS at 65°C for 10 – 20 min. F ally, the membrane was washed 
with 0.2 x SSC containing 0.1 % SDS at the hybridisation temperature. After drying the 
filter, it was sealed in Saran wrap and exposed to au radiography overnight at -80°C. The 
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2.2.14 Histological techniques 
 
2.2.14.1 Tissue preparation for paraffin-embedding 
 
The freshly prepared tissues were fixed in Bouin’s solution or 4% (w/v) 
paraformaldehyde for 6 - 24 hours to prevent alterations in the cellular structure. The 
dehydration process was accomplished by passing the tissue through a series of increasing 
alcohol concentrations, i.e. 70%, 80%, 90%, 96%, 100% ethanol for 1 hour at RT and 
isopropanol overnight. Later, the alcohol was removed from the tissue by incubation in 25%, 
50%, 75% and 100% xylene. Next step was incubation of the tissues in paraffine at 60°C for 
12-24 hours. Before embedding, the paraffin was changed at least three times. Finally, the 
tissue was placed in embedding mold and melted paraffin was poured into the mold to form 
a block. The block was cooled and became ready for sectioning. 
 
2.2.14.2 Sections of the paraffin block 
 
Paraffin blocks were clamped into the microtome (Hn 40 Ing., Nut hole, Germany). The 
thickness of the section was 5 µm. The sections were floated on 40°C water to allow actual 
spread. Then, they were put onto slides. After complete drying at 37°C, slides were stored at 
4°C for further analysis. 
 
2.2.14.3 Immunofluorescence staining  
 
For mouse tissues: 
Tissue sections were incubated twice for 10 min in xylene to remove the paraffin. 
Then, they were re-hydrated in a decreasing ethanol series (100%, 96%, 70%, 50%, and 
30%) for 2 min each. For immunofluorescence staining, the sections were washed in PBS 
and then incubated with a blocking solution containing 10% goat serum and 0.02% Tween-
20 in PBS for 2 hours at RT. Then, they were incubated with primary antibodies for 
overnight in a humidified chamber at 4°C. Subsequently, they were rinsed three times for 5 
min in PBS and an appropriate secondary antibody was put for 1 hour. Finally, the slides 
were washed three times for 5 min in PBS and the nuclei were counterstained with DAPI. 
Immunostaining of the sections was examined using a fluorescence equipped microscope 
(BX60; Olympus). 
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For cells: 
Cells were fixed in 4% paraformaldehyde in PBS for 15 min at 4oC , rinsed in PBS 
and incubated in 50 mM NH4Cl (PBS) for 10 min at RT. After washing in PBS (2 x), the 
cells were 3 x washed in 0,2% Triton X-100 (PBS) for 4 min. Next, the primary antibody 
with appropriate dilution was applied for overnight at 4oC. Cells were washed 2x in 0,2% 
Triton X-100 (PBS) for 4 min and incubated with Cy3- conjugated IgG for 1 hour at RT. 
One drop of mounting medium with DAPI was dispensed onto the slides after washing with 
PBS. Fluorescent cells were visualised with Olympus BX60 microscope. 
 
2.2.14.4 Phalloidin staining of cells 
 
 Cells were washed twice in PBS for 5 min, fixed for 15 min (4oC) in 4% 
paraformaldehyde and washed 3 times in PBS. Then, they were incubated for 1 hour in 
phalloidin (diluted 1:1000) conjugated with Cy3 and washed 3 times in PBS. The slides 
were mounted with DAPI-containing medium. 
 
2.2.14.5 Alkaline phosphatase staining of cells 
  
 Cells were washed with PBS, fixed for 30 sec. with fixation solution (Sigma) and 
washed with dH2O for 1 min. Incubation with staining solution was pplied for 15 min in 
RT. Next, the cells were washed for 2 min in water nd incubated with neutral red for 10-20 
sec. Afterwards, they were washed in tapped water and left for drying. 
  
2.2.14.6 Hematoxylin-eosin (H&E) staining of the histological sections 
 
Tissue sections were first incubated three times in xylene for 3 min each, followed by 
incubation in 100% for 3 min, 95% and 80% ethanol for 2 min each. Thereafter slides were 
washed in dH2O for 5 min and stained for 3 min in hematoxylin. The staining was followed 
by rinsing with deionised water and washing in tap water for 10 min. The treated slides were 
dipped fast in acid ethanol (1ml concentrated HCl in 400 ml 70% ethanol) for 8-12 times to 
destain and in amonium water (0,25%), rinsed in tap w ter for 2 min and in deionised water 
for 2 min, stained in eosin for 1 min and then incubated in 70%, 80%, 90%, 95% and 100% 
ethanol for 2 min each. Finally, the stained slides w re incubated in xylene for 15 min and 
mounted with Eukitt-quick hardening mounting medium. 
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2.2.14.7 Apoptosis detection 
 
ApopTag Peroxidase Apoptosis Detection Kit was used for analysis of apoptotic 
cells in testis sections (5 µm). The sections were firstly deparafinized, dehydrated and 
washed 2 x 5 min in PBS. Next, the slides were incubated for 15 min at RT in 20 µg/ml 
Proteinase K and washed 2 x 2 min in dH2O. To block endogenous peroxidase, tissues were 
incubated in 3 % H2O2 for 5 min at RT. After 2 x 5 min washing in PBS, the tissues were 
covered for 10 sec. with equilibration buffer. Next, Working Strength TdT Enzyme (30% 
enzyme in reaction buffer) was applied for 1-hour incubation at 37oC in darkness. To stop 
the reaction, the slides were incubated for 10 min shaking at RT in Stop/Wash buffer (1:34 
in dH2O) and then washed 3 x 1 min with PBS. Next step was incubation with anti-
digoxigenin for 30 min at RT in darkness and washing 4 x 2 min with PBS. Then the slides 
were stained with Working Strength Peroxidase Substrate (2% DAB Substrate in DAB 
Dilution buffer) for 6 min at RT, washed 3 x 1 min a d 1 x 5 min with dH2O. They were 
covered by AquaPolyMount liquid.  
 
2.2.15 Eukaryotic cell culture methods 
 
 The cells were cultured at 37°C in a humidified incubator with 5% CO2. 
 
2.2.15.1 Preparation of MEFs feeder layers 
 
A frozen aliquot of MEFs was quickly thawed at 37°C and transferred to 10 ml MEF 
medium. After centrifugation at 1000 x g for 5 min, the cell pellet was gently resuspended in 
10 ml MEFs medium and plated on a 50 ml culture flask. Cells were incubated at 37°C in 
5% CO2. When the cells formed a confluent monolayer after three days, they were 
trypsinised, transferred to five 10 cm dishes and grown until they formed confluent 
monolayer, or directly treated with mitomycin C (1mg/ l) for 3 hours. Then, the cells were 
washed twice with 10 ml PBS, resuspended with 10 ml medium and centrifuged. Next, they 
were resuspended in MEFs medium and plated onto dishes, which were pretreated with 
0.1% gelatine for 30 min. The feeder cells were left to attach by incubation overnight at 
37°C, 5% CO2 or used after 2 hours of incubation. Before adding ES cells on the feeder 
layer, the medium was changed to ES cell medium. 
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2.2.15.2 Trypsinisation of eukaryotic cells 
 
Cells were washed twice with sterile PBS and incubated in minimal amount trypsin- 
EDTA (0.5 g/l trypsin, 0.2 g/l EDTA) at 37°C for 5 min. Trypsin was inhibited by addition 
of growth medium, in which the cells were subsequently resuspended. The enzyme was 
removed by centrifugation at 1000 x g for 3 min. Cells were resuspended in an appropriate 
volume of cell culture medium and transferred into a new flask/plate with medium. 
 
2.2.15.3 Cryopreservation and thawing of eukaryotic ells 
 
Trypsinised cells were spun down (1000 x g for 5 min) in 4 ml of growth medium. 
The supernatant was aspirated and the cells were resusp nded in freezing medium (DMEM, 
20% FCS, 10% DMSO). Aliquots of the cells were kept for 2 days at -80°C and then stored 
in liquid nitrogen. For revitalisation, frozen cells were quickly thawed and cells were 
inoculated in a suitable amount of growth medium, centrifuged and plated. 
 
2.2.15.4 Isolation and handling of primary mouse embryonic fibroblasts (MEFs) 
 
In order to isolate mouse embryonic fibroblasts (MEFs), pregnant female mice were 
sacrificed at 13-15 p.c. by cervical dislocation. Uterine horns were dissected and placed into 
a Petri dish containing PBS. Then each embryo was separated from its placenta and 
surrounding membranes. Embryo heads were taken for genotyping and the whole gastric 
system was removed. Such prepared embryos were sheared, put in 10 ml of trypsin-EDTA 
(1-2ml per embryo) and incubated for  aprox. 5 min. A  obtained cell suspension was 
transferred to 10 ml falcon tube and about 2 volumes of fresh medium was added, then 
cenrifugated at 1000 x g for 5 min and plated out at 1 embryo equivalent per 10 cm dish. 
Medium was changed the following day. 
 
2.2.15.5 Growth of ES cells on feeder layer 
 
One aliquot of frozen ES cells was quickly thawed at 37°C and cells were transferred 
to a 12 ml tube containing 6 ml ES cell medium. After centrifugation, the cell pellet was 
resuspended in 5 ml ES cell medium and plated on 6 cm dishes containing feeder layer. Next 
day the medium was changed. The second day, cells wre ashed with PBS, treated with 2 
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ml trypsin/EDTA at 37°C, 5% CO2 for 5 min, resuspended with 5 ml ES medium and 
centrifuged. The cell pellet was resuspended in 10 ml ES cell medium and distributed either 
to 5 or 6 dishes (6 cm) or to 2 dishes (10 cm) containing feeder layers. The cells were 
passaged every second day as described above. 
 
2.2.15.6 Differentiation of ES cells 
 
Random differentiation by generation of embryoid bodies (EBs) 
 After trypsinization, cells were transferred to sterile bacterial dish, were they were 
cultured in 10 ml ES medium without LIF for 10 days. Afterwards, EBs were either 
collected for analysis or trypsinized and plated on gelatin-coated 6-well plates in 2 ml 
medium without LIF. 
 
Neuronal differentiation (Kawasaki et al., 2000) 
Undifferentiated mouse ES cells were expanded on gelatin-coated cell culture dishes 
in Glasgow minimal essential medium (GIBCO-Invitrogen, Karlsruhe, Germany) containing 
1% fetal calf serum (FCS), 10% knockout replacement, 2 mM glutamine, 0.1 non essential 
amino acids, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol, 2000 U/ml leukemia 
inhibitory factor (GIBCO). The neuronal differentiation was induced in a culture on 
mitomycin C-inactivated PA6 feeder cells. The differentiation medium was composed of G-
MEM supplemented with 10% KSR, 2 mM glutamine, 1 mM sodium pyruvate, 0.1 mM 
nonessential amino acids, and 0.1 mM 2-mercaptoethanol. ES cells were cultured on PA6 
feeder cells in differentiation medium for 8 days before it was replaced with induction 
medium and cultured for an additional 6 days. The induction medium consisted of G-MEM 
including N-2 supplement (GIBCO), 100 µM tetrahydrobiopterin (Sigma), 200 µM ascorbic 
acid, 2 mM glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, and 0.1 
mM 2-mercaptoethanol. After 4 days of differentiation, the medium was changed daily.  On 
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2.2.16. Production of targeted embryonic stem cell clones 
 
2.2.16.1 Electroporation of ES cells 
 
ES cells, which have grown for two days in 10 cm dishes, were trypsinised. The cell 
pellet was washed in 20 ml PBS, centrifuged and resuspended in 1 ml PBS. The 0.8 ml of 
cell suspension was mixed with 40 µg of linearised DNA-construct and transferred into an 
electroporation cuvette. The electroporation was performed at 240V, 500µF with the Bio-
Rad gene pulserTM apparatus. After electroporation, the cuvette was placed on ice for 20 
min. The cell suspension was transferred from cuvette into 20 ml of ES cell medium and 
plated onto two 10 cm dishes containing feeder layers. The medium was changed every next 
day. Two days after the electroporation, the drugs for selection were added (active G418 at 
400µg/ml and gancyclovir at 2 µM). The medium was changed every day. After about eight 
days of selection, drug resistant colonies have appe red and were ready for screening by 
Southern blot analysis. 
 
2.2.16.2 Growing ES cells for Southern blot analysi 
 
The drug resistant colonies that were formed after about eight days of selection were 
picked with a drawn-out Pasteur pipette under a dissecting microscope. Each colony was 
transferred into a 24-well plate containing feeders and ES cell medium. After 2 days, the ES 
cells were trypsinised with 100 µl trypsin for 5 min and resuspended in 500 µl ES cell 
medium. Half of the cell suspension in each well was tr nsferred to a well on two different 
24-well plates, one gelatinised plate, and the other containing feeder cells (master plate). 
The gelatinised plate was used for preparing DNA and the master plate was kept frozen. 
 
2.2.17 Flow cytometry (FACS) procedure for apoptosi detection and cell surface 
staining (Kanwar et al. 2008) 
 
1×106 cells per measurement were washed in 5-ml tubes with PBS and resuspended 
in 100 µl PBS before cell surface staining with 1 µg of the respective antibodies: anti-CD3 
(clone CT-CD3, rat IgG2a, phycoerythrin [PE]-labeled; Caltag Laboratories, Hamburg, 
Germany), anti-CD4 (clone CT-CD4, rat IgG2a, PE or tricolor [TC]-labeled; Caltag), anti-
CD8a (clone CT-CD8a, rat IgG2a, fluorescein isothiocyanate [FITC] or PE-labeled), anti-
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CD8b (clone CT-CD8b, rat IgG2a, PElabeled; Caltag), nti-CD19 (clone 6D5, rat IgG2a, 
FIT C-labeled; Caltag), anti-CD25 (clone 7D4, rat IgM, FITClabeled, Becton Dickinson), 
anti-CD45R/B220 (clone RA3-6B2, rat IgG2a, PE-labeled; Caltag). TC-conjugated 
streptavidin (SA1006, Caltag) was used as the secondary reagent. Appropriate isotype 
controls were purchased from Caltag Laboratories. The cells were stained for 45 min at 4°C 
before being washed and resuspended in 200 µl PBS.  
Exposure of phosphatidylserine as a membrane parameter of apoptosis was 
determined by staining cells for 45 min at 4°C in bi ding buffer (10 mM HEPES/NaOH, pH 
7.4, 140 mM NaCl, 2.5 mM CaCl2) with 5 µl annexin V-FITC (Becton Dickinson) in 
combination with 1 µg/ml propidium iodide (Sigma) to distinguish early apoptotic from late 
apoptotic or necrotic cells. The cells were resuspended in 200 µl annexin binding buffer 
before measurement. DNA histograms were obtained aft r propidium iodide staining of cells 
fixed in ethanol as described previously (Ormerod et al. 1992; Dressel et al. 2000). Flow 
cytometry was performed on a FACScan flow cytometer with CellQuest software (Becton 
Dickinson, Heidelberg, Germany); 10,000 to 50,000 cells per sample were counted. 
 
2.2.18 Production of chimeras by injection of ES cells into blastocysts 
 
The standard procedure is to inject 10-20 ES cells from 129/Sv, which are 
recombinant for the targeted locus, into the blastocoel cavity of recently cavitated 
blastocysts that have been recovered by flushing the uteri of day 4 pregnant mice 
(C57BL/6J). After injection, embryos are cultured for a short period (2-3 hrs) to allow re-
expansion of the blastocoel cavity and then transferred to the uterine horns of day three 
pseudopregnant mice. Pseudopregnant females are obtained by mating 6-8 weeks old 
oestrous females with vasectomised males. Chimeric mice have been generated in Max 
Planck Institute for experimental medicine. 
 
2.2.19 Detection of chimerism and mice breeding 
 
Chimeric males (and sometimes females) are bred to wildtype mice to ascertain 
contribution of the ES cells to germline. Once a germline chimera has been identified, the 
first priority will be to obtain and maintain the targeted allele in living animals. The 
chimeras were bred with C57BL/6J. 
 
MATERIALS AND METHODS 
 41 
2.2.20 Preparation of cKO ESCs from cKO mice 
 
 Uterus was isolated from pregnant (E3.5) female and both its horns were cut to open 
it. Next, it was flushed with M2 medium through opened horns to wash out the blastocysts 
onto the plate. Then, the blastocysts were collected and transferred to KO medium on 
gelatine-pretreated plate. After 4 days, one could observe ESCs growing on the layer of 
trophoblast cells. The clones were picked and plated into separate wells of 24-well plate 
with feeder layer, they were cultured in ES medium. To confirm their genotype, genomic 
DNA was isolated and genotyping PCR was performed. 
 
2.2.21 Tamoxifen (TAM) treatment of mice 
 
 The adult mice were injected intraperitoneally with 1 mg / day for 5 days. 10-day-old 
and 15-day-old mice were injected with 0.2-0.3 mg dose per day depending on the weight. 
 
Preparation of tamoxifen 
 50 mg TAM were suspended in 500 µl 100% ethanol. Next, 4 ml of sunflower oil 
was added and it was mixed till powder was dissolved. An obtained solution (1mg/100 µl) 
was aliquoted and stored in -20oC max. for 4 weeks. 
 
2.2.22 Hydroxytamoxifen (OHT) treatment of generated cKO ESCs 
 
 Cells were treated with 1 µM OHT for 2 days what resulted in complete silencing of 
floxed pelota allele. 
 
2.2.23 Generation of teratomas in SCID mice 
 
 SCID (Severe Combined Immuno Deficiency) mice, resid nt in the Institute of 
Human genetics in Göttingen, were injected with 106 ES cells suspended in 200 µl PBS. The 
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2.2.24 Bone marrow transplantation 
 
 Bone marrow of TAM-treated cKO mice was isolated by flushing femoral bones of 
TAM-treated mice. After washing in PBS, the cells were counted. 3x 106 cells were 
intravenously injected to immune-defficient mice, rsident in the institute. 
 
2.2.25 Fertility test of Stra8 mice 
 
 To check fertility of deficient mice, they were bred with wild type mice. If female 
mouse became pregnant it meant that mutant male was fertile. The offsprings were counted 
to estimate if subfertility appeared. 
 
2.2.26 Preparation of adaptor oligos 
 
Sequences of linkers were designed as follows: 
Linker containing LoxP site  
5’ AGCTTGGTACCATAACTTCGTATAGCATACATTATACGAAGTTATGAATTCA 3’ 
5’ AGCTTGAATTCATAACTTCGTATAATGTATGCTATACGAAGTTATGGTACCA 3’ 
KpnI/Tsp509I linker  
5’ GACTGTCGACACT 3’ 
5’ AATTAGTGTCGACAGTGGTAC 3’ 
SpeI/XhoI/NotI linker 
5’ CTAGTACTACTACTCTCGAGACTGC 3’ 
5’ GGCCGCAGTCTCGAGTAGTAGTA 3’ 
 
Both oligonucleotides (8 µl 10 µM of each) of each linker were subsequently 
annealed in 45 µl of 1x annealing buffer in following program: 
94oC – 4 min; 85 oC – 4 min; 75 oC – 4 min; 70 oC – 4 min; 68 oC – 10 min; 65 oC – 10 min; 
62 oC – 10 min; 60 oC – 10 min; 58 oC – 10 min; 56 oC – 10 min; 53 oC – 4 min; 37 oC – 15 
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2.27 Computer analysis 
 
For the analysis of the nucleotide sequences, programs like BLAST, BLAST2, 
MEGABLAST and other programs from National Center fo Biotechnology Information 
(NCBI) were used (www.ncbi.nlm.nih.gov). For protein studies ExPASy tools 
(www.expasy.ch) were used. Mouse genome sequence and other analysis on mouse genes, 

































3.1. Generation and characterization of pelota conditional knockout mouse 
 
The lethality of pelota conventional knockout embryos (Pelo-/-) at postimplantation 
stage became an essential obstacle to determination of pelota function in different 
developmental processes, such as organogenesis, gametogenesis and tumorgenesis. 
Furthermore, we were not able to establish Pelo-deficient cell lines, which can help to 
describe the molecular role of Pelo in stem cell self-renewal and RNA decay. To overcome 
this early lethality of Pelo-/- mice, we have generated a conditional knockout mouse model 
using Cre/LoxP system to inactivate pelota in a tissue-specific and time-controled manner 
(Lakso et al., 1992; Pichel et al., 1993). 
 We have constructed a pelota conditional knockout (cKO) allele, where the exons 2 
and 3 are flanked with two LoxP elements. We expected that insertion of these elements in 
introns 1 and 3 would not disrupt the expression of floxed Pelo allele (PeloF) and thereby 
Peloflox/flox (allele flanked by LoxP sites) mice would develop normally.  To silence th  gene, 
that is to excise the LoxP-flanked region of PeloF allele, we have generated three mouse 
lines by introduction of three transgenic Cre recombinase alleles in the genome of PeloF/F r 
PeloF/- (Fig. 3). 
 
 
Figure 3. Simplified scheme of conditional knockout (cKO) system 
Blue squares represent pelota exons, whereas green on  is a symbol of Neo cassette. Pink 
triangles stand for LoxP sites, which are recombined upon Cre recombinase activation. 
 
 EIIaCre recombinase is expressed under the control of adenovirus EIIa promoter 




Therefore, we expected that Cre-mediated recombination would occur at one-cell stage and 
effectively delete LoxP-flanked Pelo fragment (Williams-Simons and Westphal, 1999). The 
PeloF/FEIIaCre line was generated in order to determine whther obtained Pelo∆/∆ or Pelo∆/- 
embryos would die at E7.5 mimicking the classical knockout mouse (Pelo-/-) phenotype. 
 Second Cre recombinase helped us with functional ch racterization of pelota in 
spermatogenesis. The transgenic Stra8-Cre allele (gnerated by Dev and Shirneshan) was 
introduced into the second line. The recombinase is xpressed under Stra8 (stimulated by 
retinoic acid gene 8) promoter. Its expression is limited to spermatogonia (Oulad-
Abdelghani et al., 1996; Baltus et al., 2006). We expected that excision of floxed pelo allele 
would occur in spermatogonia and their derivative cells. 
 For spatiotemporal inactivation of PeloF/F allele we used ubiquitously expressed 
Rosa26-CreERT knock-in allele (available in the Institute of human genetics). The Cre 
recombinase is fused with the ligand-binding domain of human estrogen receptor (ERT) that 
binds tamoxifen (TAM) but not estrogen. The floxed pelota allele can be excised in various 
tissues and cultured cells after administration of tamoxifen to animals. The mouse line 
allows the study of the effects of pelota disruption on development of different tissues. It 
also enabled us to establish PeloF/FCreERT embryonic stem cells (ESCs) for identification of 
the role of PELO in proliferation and differentiation. 
 
3.1.1. Generation of  a conditional knockout (cKO) construct 
 
The 12.5-kb-long genomic fragment (containing the pelota gene and its flanking 
regions) was used for the generation of the pelota cKO construct. To clone a 5’ region of the 
construct, a 1622 bp PstI/EcoRI fragment composed of third exon (clone 1 in Fig. 4A) was 
cloned into pBluescript vector (clone 2 in Fig. 4B). Next, clone 1 was digested with SpeI and 
PstI enzymes in order to obtain 1573 bp fragment containing part of first exon and the whole 
second exon. After cloning into pGEMTeasy vector, clone 3 (Fig. 4C) was digested with 
HindIII , dephosphorylated and ligated with a linker containing LoxP element (pink triangle 
in Fig. 4D) and KpnI/EcoRI restriction sites (clone 4, Fig. 4D). To ligate both fragments 
possessing exons,  a SpeI/PstI-digested insert of clone 4 was ligated into clone 2 r sulting in 













Figure 4. The scheme representing cloning strategy for generation of 5’ region of 
conditional knockout construct. 
A – clone 1; B – clone 2; C – clone 3; D – clone 4; E – clone 5; F – clone 6; G – clone 7, 
EcoRI* - inactivated EcoRI site; H – clone 8; I – clone 9. Dotted lines stand for vector 
sequences; pink triangle is a symbol of LoxP site; red lines – linker sequence;  detailed 
description of the figures in the text. 
 
 
To construct 5’ region, clone 1 (Fig. 4A) was digested with EcoRI and SpeI. The 
obtained 6052-bp-long fragment was subcloned into pBluescript (clone 6 in Fig. 4F). To 
enable further cloning, one needed to exclude EcoRI and XhoI sites from clone 6. To reach 
the goal, a KpnI/Tsp509I linker containing KpnI, SalI and Tsp509I sites was designed (Fig. 
4F). It was cloned into clone 6 digested with KpnI and EcoRI. Tsp509I end is compatibile 
with EcoRI, but such ligation leads to inactivation of the EcoRI site in clone 7 (Fig.4F, G). 
Subsequently, another linker (SpeI/XhoI/NotI) was cloned into SpeI/NotI digested clone 7 
(clone 8 in Fig. 4H). SpeI/SalI fragment from clone 5 (Fig. 4E) was isolated and cloned in 
SpeI/XhoI-digested clone 8 to give clone 9 (Fig. 4I). SalI and XhoI restriction sites are 
compatibile in an analogous way to EcoRI and Tsp509I, so XhoI site was eliminated from 
the final clone 9 (Fig. 4I, marked in red). 
Next step was the generation of 3’ homologous region. Clone 1 (Fig. 4A) was 
digested with EcoRI and a 3.3kb-long fragment was subcloned into pBluescript (Fig. 5A). 
To exclude SpeI site from multicloning site of clone 10, it was digested with BamHI and 
NotI, filled-up by T4 Polymerase and blunt-end ligated (Fig. 5B). To elongate the 3’ arm it 




region. After amplification (by using 3’regionA_F and 3’region_R primers), the 1.47 kb 
fragment was inserted into pGEMTeasy vector to generate clone 12 (Fig. 5C). Sequencing 
of the product confirmed the lack of mutations. To finish the 3’ arm of the construct, 






Figure 5. The scheme representing cloning strategy for generation of 3’ homologous 
region of conditional knockout construct. 
A – clone 10; B – clone 11, NotI*/SpeI*/BamHI* - removed restriction sites; C – clone 12; 







 Last step of the construct preparation was cloning of both generated regions into final 
vector pPNT4. SalI/NotI fragment of clone 9 (Fig. 3I) was inserted upstream from the LoxP 
site of the vector, whereas EcoRI/XhoI insert from clone 13 (Fig. 5D) was introduced 
downstream from neomycin phosphotransferase (Neo) gene. Downstream from 3’ arm in the 
vector, Herpes simplex virus thymidine kinase (TK) gene was located what enabled negative 
selection of embryonic stem cells (ESCs) transfected with the construct (Fig. 6). 
 
 
Figure 6. Final conditional knockout construct. 
Exons 2 and 3 are flanked by LoxP elements (pink trangles). The neomycin cassette (Neo) is 
flanked by Flp/FRT elements (orange ovals). Red dotte  lines stand for homologous arms of 
the construct; TK – thymidine kinase. 
 
 
3.1.2. Isolation of homologous recombinant ESC clones 
 
R1 ES cells were trypsinized, washed and suspended i  PBS. Approximately 2 x 107 
cells/ml were mixed with 40 µg linearized construct (digested with SalI) and the mixture 
was electroporated at 240V and 500 µF using a Bio-Rad Gene Pulser apparatus.  The 
transfected cells were plated on G418–resistant mouse embryonic fibroblasts (MEFs) and 
cultured in nonselective medium for 36 hours. Then s lective medium was applied for 10 
days. Afterwards, resistant clones were picked and further cultured on 24-well plates for 
DNA isolation and cell freezing. 
To find a correct homologous recombinant ESC clone, DNA of 100 ESC clones were 
screened by Southern analysis using 5’ external probe (Fig. 7). After DNA digestion with 
EcoRI, a 15 kb band was expected for the wild type allele and a 13 kb band for the flox 
allele (Fig. 7). I found 42 clones that gave correct results. Four of them were selected for 
further analysis. BsrGI- and AseI-digested DNA was hybridized with 3’ external and iternal 
probe, respectively (Fig.7). As shown in Fig. 8, ESC clone no. 22 and 60 turned out to be 
correct, bands of expected size were detected (Fig. 8B, C). To confirm the absence of 
additional insertion of cKO construct in other loci of ESC genome, BsrgI-digested DNA of 
the clones was hybridized with the probe for Neomycin cassette. The expected result was 




(Flox allele) and a 5.2kb fragment (wild-type allele) in AseI-digested DNA, what further 
confirmed the lack of another insertion. The clone 60 was chosen for blastocyst injection. 
 
 
Figure 7. A schematic diagram of conditional knockout (cKO) allele  
WT – wild type allele; Flox – conditional knockout allele; Delta – cKO allele after deletion 
of floxed region between LoxP sites (pink triangles); “-“  – classical knockout allele. The 
hybridization of EcoRI-digested genomic DNA with the 5’external probe results in a 15-kb 
band for WT and a 13-kb band for the Flox allele (pink color); BsrGI-digested DNA 
hybridized with 3’ext probe results in 13.5-kb band for WT and 15.2-kb band for Flox allele 
(black color);bands obtained by hybridization of AseI-digested DNA with the internal probe 
(3’ probe, 266bp) are marked in green color. Primers used in genotyping: F1 = Pelo_F11, 











Figure 8. Southern analysis of ESC clones transfectd with conditional knockout 
construct. 
A – DNA digested with EcoRI and hybridized with 5’ external probe; B – DNA digested with 
AseI and hybridized with internal probe (3’ probe,266bp); C – DNA digested with BsrGI 
and hybridized with 3’ external probe; D – DNA digested with BsrgI and hybridized with 
Neo probe. Red colour – size of mutant band. 
 
 In summary, hybridization of external probes showed correct homologous 
recombination of the 5’ and 3’ arms of the construct, whereas results obtained from internal 
and Neo probes confirmed that there was only one integration site of the cKO construct. 
 
3.1.3. Generation of chimeric mice 
 
 Recombinant ES cells were injected into blastocysts derived from C57Bl/6J mouse 
strain in Max Planck Institute for experimental medicine in Göttingen. The blastocysts were 
then transferred into pseudopregnant CD1 females. I obtained 7 chimeric males from clone 
no. 60, chimerism of which ranged from 20 to 100%, and 4 chimeric males from clone no. 
22 with chimerism between 10 and 80%. Two  chimeras (90-100%) from each line were 
bred with C57Bl/6J females. All of them transmitted the cKO allele to their offsprings. For 
determination of the genotypes in F1 generation, a set of PCR primers were designed (Fig. 
7), which amplify 376 bp-long band for flox allele and 330 bp-long fragment for wild type 





Figure 9. Genotyping PCR for F1 generation of Pelota cKO mice. 
376bp – flox allele; 330bp - wild-type allele. PCR conditions are presented in chapter 
2.2.8.1. 
 
 Mice of F1 generation (PeloF/+) displayed no abnormalities – they were healthy and 
fertile. When bred together (♂PeloF/+ x ♀PeloF/+), they yielded PeloF/F offspring which were 
viable and fertile as well. These results revealed that the introduction of neomycin cassette 
and LoxP elements into introns of pelota gene did not disrupt its expression. 
 
 
3.1.4. Generation of  an ESC line 
 
For more comprehensive studies of pelota influence on differentiation and cell cycle 
progression, we generated a PeloF/-CreERT embryonic stem cell line. To establish the ESC 
line, blastocysts (E3.5) were isolated from PeloF/-CreERT females mated with PeloF/-
CreERT males. After 4 days of blastocyst culture, when the proliferating inner cell mass 
(ICM) caused a break of zona pellucida, one could observe trophoblast cells attached to the 
bottom and ICM growing on them. Such generated ESCs were genotyped - clone 9 (PeloF/-
CreERT) and 1 (PeloF/F) were chosen for further experiments. To induce Cr-mediated 
silencing of pelota gene, both clones were treated with 1 µM hydroxytamoxifen (OHT) 
which is more suitable for cultured cells than tamoxifen applied for mice treatment. A 
genotyping PCR showed that one-day presence of OHT in medium was sufficient to excise  
the floxed region from the allele of mutant cells (Fig. 10). OHT did not influence viability 
and differentiation ability of control cells (PeloF/F). It proved that applied OHT concentration 
was not toxic to the cell. 
Pelota deletion was also demonstrated by Northern analysis (Fig. 11). Pelota RNA is 
clearly visible in control and mutant ESCs which were not treated with OHT. After addition 
of OHT into the medium, pelota expression is stopped in the mutant cells while in control 





Figure 10. Genotyping PCR for OHT-treated ESCs. 
1 – ESC control clone 1; 9 – ESC mutant clone 9; 24 – ESC control clone F/- without 
CreERT; NEG – negative control for PCR. Wild type band visible in ESC lanes comes from 
feeder layer (mouse embryonic fibroblasts), on  which ESCs are cultured. Size of 
products: ”-“ band – 172bp; “+” band – 330bp; flox band (F) – 376bp; delta band (D) – 
455bp 
 
Figure 11. Northern analysis of pelota expression in OHT-treated and untreated ESCs. 
F/- are control cells because they do not possess CreERT recombinase. First 2 samples are 
not treated and 2 last are OHT-treated ESCs. The good quality of RNA is demonstrated in 
the picture of the gel by RNA of 28S subunit. 
 
Pelota-deficient cells did not exhibit any growth impairment – their morphology did 
not differ from control ESCs. They were successfully preserved in the culture. 
 
3.1.5. Conditional knockout system– verification of recombination efficiency by 
generation of cKO/EIIaCre mouse line 
 
 To examine the recombination efficiency of floxed pelota allele and to determine 
whether the deletion of Pelota during early embryogenesis results in a phenotype similar to 












allele into the genome of cKO mice (Lakso et al., 1996). The Cre recombinase allele is 
controlled by adenovirus EIIa promoter which is activated in one-cell stage embryo. 
Therefore, we expected that floxed pelota allele would be recombinated at zygote stage.  
The breeding strategy was as follows: we bred heterozygous Pelo+/- mice with Pelo+/+ 
EIIaCreT/- transgenic animals to obtain Pelo+/- EIIaCre which were further bred with 
PeloFlox/+. The mice were genotyped by using two PCRs (Fig. 12) to determine the genotype 
of pelota locus and the presence of transgenic EIIaCre llele. 
 
Figure 12. Genotyping PCRs for cKO/EIIa mice 
A – flox/-/∆ PCR for determination of the genotype of pelota locus, B – EIIa PCR 
demonstrating the presence of EIIaCre allele. 1: PeloF/+CreEIIa mouse, 2-4:PeloF/-CreEIIa, 
5: Pelo+/+ . Size of products of flox/-/ ∆ PCR:  455bp – deleted allele; 376bp – flox (F) allele; 
330bp – wild-type allele; 172bp – classical KO allele. Size of transgene band: 450bp. 
Primers were designed in transgene sequence what explains lack of the band in wild-type 
animal (+/+). PCR conditions are presented in chapter 2.2.8.1. 
 
 
We predicted that Pelo∆/-CreEIIa offsprings would die at early embryonic stage. 
There were no Pelo∆/-EIIaCre animals out of 219 genotyped mice of F1 generation. 
According to Mendelian ratio, Pelo∆/-EIIaCre should constitute 12.5% of all offsprings in the 
breeding of Pelo+/-CreT/- and PeloF/+ (Table 1). Moreover, this genotype was also not found 
in further generations (180 mice tested).  
 
 
Table 1. Statistics of genotypes obtained in F1 generation from cKO/EIIaCre mouse line 
Pelo+/-CreT/-  x   PeloF/+ 
F1 generation +/+ +/- F/+ F/- +/+ T/- +/- T/- ∆/+ T/- ∆/- T/- 
Mendelian ratio 1 1 1 1 1 1 1 1 
Mice number (out of 219) 33 29 25 41 36 29 26 0 





The results clearly demonstrated that Cre-mediated recombination efficiently excises 
pelota-flanked region in one-cell stage of mouse development, i.e. Pelo∆/- EIIaCre died 
during prenatal stages (like Pelo-/-). To obtain more evidence, embryos (E8.5) from breeding 
of Pelo∆/+CreEIIa mice were genotyped. None out of 7 isolated embryos was Pelo∆/∆ EIIaCre. 
Three deciduas were found empty and degenerated. It indicated that the absorption of dead 
embryos had occured. These results suggest that Pelo ∆/-CreEIIa have a phenotype similar 
with classical pelota knockout mice (Adham et al., 2003). 
 
 
3.1.6. The role of Pelota in germ cell development - testis-specific cKO/Stra8-Cre 
mouse line 
 
 To analyze Pelota impact on spermatogenesis, we introduced a Stra8-Cre 
recombinase allele to the genome of PeloF/F cKO mice. Expression of Stra8 is germ-cell-
specific and has been reported in spermatogonia (Oulad-Abdelghani et al., 1996) and 
premeiotic germ cells of embryonic ovary (Baltus et al., 2006). According to Stra8 
expression, we expected that pelota would be exclusively deleted in spermatogonia  and we 
would be able to verify pelota involvement in self-renewal of germ stem cells. 
 
3.1.6.1 Generation of PeloF/-Stra8-Cre mouse 
 
 Heterozygous Pelo+/- mice were bred with transgenic Pelo+/+Stra8-CreT/- to obtain 
Pelo+/-Stra8-Cre mice, which were further bred with PeloF/F mice. We genotyped the 
offsprings using flox/-/∆ PCR amplifying all alternatives of Pelo allele and PCR 
demonstrating presence/lack of Stra8-Cre in mouse genome (Fig.13). In F2 generation we 
detected all expected genotypes (Table 2). Peloflox/-Stra8-Cre mice, which are the actual 
model for study of spermatogenesis in pelo-deficient mice, were also found.  It indicates that 





Figure 13. Genotyping PCRs for cKO/Stra8-Cre line.  
The figure shows pictures of PCR products loaded on gel. PCR flox/-/∆ products are Pelo∆ 
(455bp), PeloF (376bp), Pelo+ (330bp), Pelo- (172bp). Transgene-specific band is 1100bp 
long. Primers were designed in transgene sequence what explains lack of the band in wild-
type animal. PCR conditions are presented in chapter 2.2.8.1. 
 
 
Table 2.  Statistics of male genotypes obtained in F2 generation from cKO/Stra8-Cre 
mouse line 
 
Pelo+/-Stra8-CreT/-  x   PeloF/F 
F2 generation F/+ F/- F/+Cre F/-Cre 
Mendelian ratio 1 1 1 1 
♂ Number (out of 66) 14 17 19 16 
Percentage (%) 21.2 25.8 28.8 24.2 
 
 
However, by genotyping the mice of this line we found 9 males and 5 females which 
were Pelo∆/+Cre. It suggests that Stra8-Cre-mediated recombination occurs in some somatic 
cells. Intrestingly, no chimeric Pelo ∆/F/-Stra8-Cre offspring was detected. To examine the  
Cre recombination range resulting in pelota deletion, DNA from various tissues of two 
Pelo∆/+Stra8-Cre animals was isolated and genotyped. The mosaic genotype was found in all 
studied organs (Fig. 14).  The result suggests that Cre recombinase under Stra8 promoter is 
activated during early embryogenesis of some animals and  then contributes to pelota 
excision by Cre-mediated recombination of floxed allele. The absence of PeloF/∆/-Stra8-Cre 





Figure 14. Genotyping of different organs derived from Pelo∆/+Stra8-Cre animal 
DNA from different organs was isolated by the same method as from tail DNA (chapter 
2.2.1.2.) and it was genotyped with PCR flox/-/∆. 
 
3.1.6.2. Histological analysis of testes during postnatal development 
 
 In order to check if Stra8-Cre-mediated pelota deletion influences spermatogenesis, 
we isolated testes of 6-week-old males for histological study (Fig. 15). Hematoxilin and 
eosin (H&E) staining revealed that spermatogenesis is impaired in 70% of seminiferous 
tubules of PeloF/-Stra8-Cre. The diameter of the tubules is significantly smaller than in wild 
type and Leydig cells are hyperproliferated. Germ cell differentiation is arrested at 
premeiotic stage in most affected tubules where few number of pachytene spermatocytes 
and round spermatids were observed. Additionally, one could notice numerous vacuoles. In 





































Figure 15. H&E staining of testis sections from wild-type and PeloF/-Stra8-Cre mice. 
Testes were isolated from 6-week-old animals of cKO/Stra8-Cre line. A, C – wild-type testis; 
B, D – PeloF/-Stra8-Cre testis. Sp – spermatogonia; Ps – pachytene spermatocytes; Rs – 
round spermatids; Es – elongates spermatids; V – vacuoles. A,B – 10 x magnification; C, D 
– 20 x magnification. 
 
 To define the onset of pelota influence on spermatogenesis in PeloF/-Stra8-Cre, we 
characterized the first wave of germ cell differentiation in testes of wild-type and mutant 
mice. We isolated testes from 5-, 10-, 15-, 20- and25-day-old animals, fixed and stained 
them with hematoxilin and eosin.  
 Analysis of  cross sections of 5- and 10-day-old wil -type and mutant testes revealed 
no striking differences (Fig.16A-D). At day 10 of spermatogenesis, primary spermatocytes 
appear. The number of germ cells seems to be slightly reduced compared to the wild type. 
At day 15, the differentiation reaches the stage of pachytene spermatocytes (Fig. 16E). In 
mutant testes, we observed a drastic reduction in the number of pachytene spermatocytes in 
some tubules, while the other tubules displayed the depletion of all meiotic germ cells (Fig. 
16F). Germ cell development results in round spermatids at the day 20 (Fig17A). However, 





Figure 16. H&E staining of 5-, 10- and 15-day-old testis sections from wild-type and 
PeloF/-Stra8-Cre mice. 
 A, C, E – wild-type testis; B, D, F – PeloF/-Stra8-Cre testis. G – gonocytes; Sp – 
spermatogonia; Ps – pachytene spermatocytes; V – vacuoles. Photos were taken in 20 x 
magnification). 
 
spermatocytes (Fig. 17B).  At day 25 the first round of spermiogenesis proceeds and 
elongated spermatids appear (Fig. 17C). While mutant testes displayed severe depletion of 




and vacuolization of Sertoli cells was more pronounced (Fig. 17D). These results suggest 
that spermatogenesis is disrupted at premeiotic and/or early meiotic stages.  
 
Figure 17. H&E staining of 20- and 25-day-old testi sections from wild-type and PeloF/-
Cre mice. 
 20-day-old testes are presented in picture A and B. 25-day-old testes are shown in picture C 
and D. A, C – wild-type testis; B, D – PeloF/-Cre testis. Sp – spermatogonia; Ps – pachytene 
spermatocytes; Rs – round spermatids; V – vacuoles; Gc – monster cells. Photos  were 
taken in 20 x magnification. 
 
Due to severe impairment of spermatogenesis and loss of cells in particular tubules, 
we performed a TUNEL-assay (the terminal deoxynucleotidytransferase-mediated dUTP-
Biotin nick end labeling) in order to verify if enhanced apoptosis i the reason of germ cell 
depletion. We examined the apoptosis levels in testes of 5-, 10-, 15-, 20 and 25-day-old mice 
(Fig. 18). In comparison to control mice (wild-type), PeloF/-Stra8-Cre did not show any 
difference in apoptosis level until postnatal day 10. However, starting with day 15 we could 
observe a significant increase in number of apoptotic cells, most of which seemed to be in 
the meiotic prophase. Hence, enhanced level of apoptosis may be the cause of germ cell 






Figure 18. Apoptosis analysis of testis sections from wild-type and and PeloF/-Stra8-Cre 
mice. 
Testes were isolated from 5-, 10-, 15-, 20- and 25-day-old  mice. Left panel – wild-type 
testes; right panel – PeloF/-Stra8-Cre testes. The arrows indicate apoptotic cells. Photos 








3.1.6.3. Spermatogenesis of PeloF/-Stra8-Cre mice is affected at premeiotic stages 
 
To determine the developmental stage, at which spermatogenesis is arrested in 
mutant testis, we performed immunohistochemical analysis using premeiotic (Hsp-110, 
GCNA1) and meiotic (HSPA4L) markers. 
HSP110 protein is expressed ubiquitously, but its hghest level is observed in 
gonocytes. Immunohistochemical analysis of 5- and 10-day-old testes with antiHSP110 
antibody revealed that the number of  HSP110-positive cells exhibits a twofold reduction in 
tubules of  5-day-old PeloF/-Stra8-Cre mice in comparison to the control (Fig.19A,B). 
 
Figure 19. Immunohistochemical analysis of Hsp110 in testis sections from wild-type and 
PeloF/-Stra8-Cre mice at day 5 and 10 of spermatogenesis 
Testes were isolated from 5- and 10-day-old mice. A – wild-type testis; B – PeloF/-Stra8-Cre 
testis. The arrows show  spermatogonia. Photos  were taken in 20 x magnification. 
 
Reduction of germ cells  was also visible at day 10, but exact estimation of cell 
number was impossible at that stage due to staining quality (Fig.19C,D). 
 The second premeiotic marker that we used, was GCNA1 (germ cell nuclear antigen). 




We performed GCNA1 staining on 5-, 10- and 15-day-old testis sections of mutant and 
control mice (Fig. 20, 21) to further confirm the premeiotic impairment of spermatogenesis. 
In 5-day-old testes we could see no significant difference in number of GCNA1-positive 
cells between the mutant and the conltrol (Fig. 20A-D). Staining was specific for cells 
localized as spermatogonia in the tubules. However, at the age of 10 day we found app. 24% 
of germ cell-depleted tubules in testes of PeloF/-Stra8-Cre mice (Fig. 20F, H), where no 
GCNA1-positive cells could be detected. In the contr l all seminiferous tubules contained 
spermatogonia and primary spermatocytes stained with GCNA1 (Fig. 20E, G). 
 In testes of 15-day-old control mice, GCNA1-positive cells, i.e. 
spermatogonia and spermatocytes, constituted peripheral multi-cell layer in each tubule (Fig. 
21A, C). Mutant testes were composed of reduced number of GCNA1-stained cells. We 
found a significant increase of seminiferous tubules, which lacked GCNA1-positive germ 






Figure 20. Immunohistochemical analysis of GCNA1 intestis sections from wild-type and 
PeloF/-Cre mice at day 5 and 10 of spermatogenesis. 
Testes were isolated from 5- (A-D) and 10-day-old (E-H) mice. Wild-type testes are 
presented in the left panel (A, C, E, G), whereas PeloF/-Stra8-Cre testes are demonstrated in 
the right panel (B, D, F, H). Stars stand for tubuli devoid of spermatogonia. Photos were 






Figure 21. Immunohistochemical analysis of GCNA1 intestis sections from wild-type and 
PeloF/-Cre mice at day 15 of spermatogenesis. 
Testes were isolated from 15-day-old mice. A, C – wild-type testis; B, D – PeloF/-Stra8-Cre 
testis. Star stands for degraded tubuli. Photos were taken in 10 and 20 x magnification. 
 
We used a specific antibody against HSPA4L (heat shock 70kDa protein 4-like 
/Apg1) for immunohistochemical analysis of testis sections from 15-day-old mice. HSPA4L 
is expressed from late pachytene spermatocytes and all germ cell stages thereafter (Held et 
al., 2006). We detected the number of tubules containi g HSPA4L-positive cells in mutant 
testes as compared to wild type is reduced (Fig. 22A,B) 
On the basis of these immunohistochemical results, we can assume that PELO 







Figure 22. Immunohistochemical analysis of APG1 in testis sections from wild-type and 
PeloF/-Cre mice at day 15 of spermatogenesis. 
 
3.1.6.4. Quantitative expresion analysis of premeiot c markers in PeloF/-Stra8-Cre mice 
 
For further verification of the germ cell developmental stage disrupted in mutant 
testes, we examined the expression of various premeiotic molecular markers by quantitative 
RT PCR (qRT-PCR). We prepared testis cDNA from 5-, 10-, 15- and 20-day-old mice and 
used it in real time PCR analysis by means of primers specific for genes expressed in 
undifferentiated spermatogonia (Plzf and Sox3), differentiated spermatogonia (c-Kit) and 
early meiotic stages (Stra8).  The results were standarized to relative expression in reference 
to expression of housekeeping gene - SDHA (succinate dehydrogenase complex subunit A). 
The analysis of the marker expression was performed using 2-3 testes of each stage and each 
genotype. 
Plzf and Sox3 genes are expressed in undifferentiatd spermatogonia (Raverot et al., 
2005). The relative expression of both markers was reduced in 5- and 10-day-old mutant 
testes compared to the control. Except for decreased expression of Plzf gene in 15-day-old 
mutant testes, there were no significant differences in the transcript level of both markers 
between mutant and control testes at 15- and 20-day-old testes (Fig. 23). 
Analysis of c-Kit, exclusively expressed in differentiated spermatogonia (Schrans-
Stassen et al., 1999), revealed no difference in relativ  expression between mutant and 
control testes of all studied developmental stages (10-, 15-, 20-day-old) apart from mutant 5-































Figure 23. Relative levels of Plzf (A) and Sox3 (B) mRNA expression in testes of 
Pelo/Stra8-Cre mice during first wave of spermatogenesis. 
Values represent relative level of Plzf and Sox3 in testes of 5-, 10-, 15- and 20-day-old 
animals (5d, 10d, 15d, 20d). Expression levels were normalised to the expression of 
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Figure 24. Relative levels of c-Kit mRNA expression in testes of Pelo/Stra8-Cre mice 
during first wave of spermatogenesis. 
Values represent relative levels of c-Kit in testes of 5-, 10-, 15- and 20-day-old animals (5d, 
10d, 15d, 20d). Expression levels were normalised to the expression of endogenous control 
(Sdha). 2-3 biological replicates were used for each stage and genotype. 
 
 
Dazl, Ddx4 and Stra8 genes are specifically expressed in spermatogonia and early 
primary spermatocytes (Ruggiu et al., 1997; Toyooka et al., 2000; Zhou et al., 2008). 
Analysis of the expression profile during postnatal development showed that expression of 
these genes was relatively low in 5-day-old wild-type and mutant testes. In day 10, when the 
first wave of spermatogenesis progresses to leptotene spermatocytes in wild-type testes, a 
drastic increase in mRNA levels of all three genes wa  observed in mutant as well as in 
wild-type testes. However, in mutants it was significantly lower. At days 15 and 20 the 
expression level is sharply decreased in both genotypes (Fig. 25). The evident reduction in 
mRNA level of Dazl, Ddx4 and Stra8 led us to assumption that leptotene is a first stage that 
is affected during the first wave of spermatogenesis in PeloF/-Stra8-Cre mice. 
 
































































Figure 25. Relative levels of Dazl (A), Ddx4 (B) and Stra8 (C) mRNA expression in testes 
of Pelo/Stra8-Cre mice during first wave of spermatogenesis. 
5d        10d     15d           20d 
5d     10d    15d        20d 
A 
B 





Values represent relative level of Dazl and Ddx4 in testes of 5-, 10-, 15- and 20-day-old 
animals (5d, 10d, 15d, 20d). Expression levels were normalised to the expression of 
endogenous control (Sdha). 2-3 biological replicates were used for each stage and genotype. 
 
 
3.1.6.5. Analysis of PeloF/-Stra8-Cre fertility  
 
 The histological and molecular analysis of mutant testes suggests spermatogenesis 
impairment at early stages (premeiotic germ cells). However, germ cell differentiation 
progresses normally in some seminiferous tubules of mutant testes. To study the 
consequences of the impairment on fertility of mutant mice, at the age of 8 weeks three 
males and three females PeloF/-Stra8-Cre were bred with wild-type animals. The number of 
offsprings was counted and is presented below (Table 3). 
 
Table 3. Results of fertility test for PeloF/-Stra8-Cre mice 
 
PeloF/-Stra8-Cre Litter size 
(mean) 
Litter number General number of 
offsprings 
♂ 9.2 9 83 
♀ 12.4 8 99 
 
 
 The fertility test showed that examined animals were fertile and there was no 
decrease in amount of offsprings in single litter. The mean litter size of mutant females was 
comparable with wild-type mice which deliver 14 offspring on average.Whereas mutant 
males produced a slightly reduced number of offsprings. 
 
 
3.1.7. Tamoxifen-dependent pelota deletion in cKO/CreERT mouse line 
 
 To study pelota function in postnatal develpment of mammals, we have generated a 
system for spatiotemporal inactivation of floxed pelota allele. We introduced ubiquitously 
expressed Rosa26_CreERT knock-in allele to the genom  f PeloF/F and PeloF/- mice. The 
CreERT recombinase is also ubiquitously expressed, but is not translocated to nucleus. The 
migration occurs upon application of tamoxifen (TAM), which binds to mutated estrogen 




the floxed pelota allele in various tissues and cultured cells after administration of tamoxifen 
to animals or hydroxytamoxifen (OHT) to the cells. In absence of the substance, the 
recombinase is not able to be transported into the nucleus what disables its function. This 
mouse model allows us to study pelota’s role in proliferation and differentiation events 
during mouse development. 
 To generate the cKO/CreERT line, we mated heterozyg us Pelo+/- mice with 
transgenic Pelo+/+CreERT mice to obtain Pelo+/-CreERT. Such mice were further bred either 
with PeloF/+ or with PeloF/F. From those crossings we achieved the actual genotype, i.e. 
PeloF/-CreERT, which after tamoxifen application will yield Pelo∆/-CreERT.  Two types of 
PCR were used for determination of the genotypes: flox/-/∆ PCR which amplify wild-type 
(+), knockout (-), flox (F) and recombined (∆) alleles (Fig. 12A) and CreERT PCR for Cre 
recombinase allele (Fig. 26). 
 
 
Figure 26. Genotyping PCR for CreERT recombinase. 
The figure presents the genotyping of 3 CreERT-positive mice (1-3) where transgenic allele 
(290bp) was detected. Primers are designed in transge e sequence what explains lack of the 
band in wild-type animal. PCR conditions are presented in chapter 2.2.8.1. 
 
PeloF/FCreERT and PeloF/-CreERT after TAM-treatment will be mentioned as mutant 
mice (Pelo∆/∆CreERT and Pelo∆/-CreERT, respectively). For the control we used mice either 
with Pelo wild-type allele (PeloF/+CreERT or Pelo+/-CreERT) or without CreERT 
recombinase (PeloF/F, PeloF/- and Pelo+/-). 
 
3.1.7.1. TAM treatment of PeloF/-CreERT mice 
 
 Originally, TAM treatment was applied (0.5mg/30g) to  adult mutant males (n=8), 
adult mutant females (3) and control mice (n=5) by intraperitoneal injections for 5 
subsequent days. After two weeks from last TAM application, one male was taken for 
histological analysis. However, all analyzed tissues were morphologically similar to the 
control. The Cre-mediated Pelo deletion had appeared, but was incomplete (data not shown). 




 Due to the fact that Pelota was shown to be involved in cell division (Castrillon et al., 
1993; Ebenhart and Wasserman, 1995; Xi et al., 2005) we have decided to treat young 
animals which still are in the phase of somatic growth. Therefore, 15-day-old mice were 
injected with TAM for 5 days. 2 days after last application of tamoxifen, we weighed the 
mice for next 9 days (Fig. 27A). The data indicate shown that Pelo∆/∆CreERT animals 
exhibit growth impairment what might be correlated with mitotic cell division disorder. 
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Figure 27. Weight gaining of mice treated with TAM at the age of 15 days. 
The mice were treated for 5 days and the weight measur ment was started 2 days after last 
injection and lasted for 9 days (A). The data were collected from 6 mutant (Pelo∆/∆CreERT 
or Pelo∆/-CreERT) and 11 control animals (B). 
 
 To verify whether the observed phenotype results from recombination of floxed 
pelota allele, DNA from various organs of mutant mice was isolated and genotyped (Fig. 
28). It  turned out that TAM-induced pelota deletion ccurs in all examined tissues at high 
extent. Partial deletion was detected in heart, lung, stomach and kidney. Only brain is hardly 





Figure 28. Genotyping PCR of organs from Pelo∆/-CreERT mouse 
Size of products: delta – 455bp; flox – 376bp. PCR conditions are presented in chapter 
2.2.8.1. 
 
 Approximately 50% of mutant animals died within 3 weeks after the treatment. It 
suggests that effective pelota ablation is a severe disturbance in mouse physiology. 
Nonetheless, 50%  of Pelo∆/-CreERT mice were able to survive, so that we could stu y their 
phenotype in detail. 
 
3.1.7.2. Effects of pelota deletion in Pelo∆/-CreERT animals 
 
 One month after TAM-application, some symptoms were found in mutant mice. 
Apart from their reduced weight, Pelo∆/-CreERT mice have begun to loose hair in the neck 
area and nose, their eyes have become dry (Fig. 29). Additionally, their tails have looked 
raspy with peeling skin. In the course of the time, th  bare skin developed erosive lesions in 
the neck, nose and around the mouth. In contrast, con rol mice remain healthy although they 
have been kept together with mutants in the same cag s. It ruled out the possibility that 






Figure 29. Apparent symptoms of pelota deletion in Pelo∆/-CreERT mouse. 
1 – loss of hair in neck area; 2 – dry eyes; 3 – hairless  and swollen nose. 
 
Dissection of mutant mice 2-3 months after TAM-treament revealed that their 
thymus and testes are extremely reduced. Histological analysis of diverse tissues of Pelo∆/-
CreERT has disclosed some abnormalities. H&E staining of skeletal muscle has shown that 
diameter of skeletal cells is decreased in mutant mice in comparison to the control, but the 
number of cells seems to be unaffected (Fig. 30). This reduction in size is probably 





Figure 30. H&E staining of skeletal muscles isolated from Pelo∆/-CreERT  
A – wild-type muscles; B – mutant muscles. Photos were taken under 10 x magnification. 
 
Histological analysis of testes revealed a severe effect of pelota depletion. In 2-
month-old wild-type testes we could observe all stages of spermatogenesis, i.e. 
spermatogonia, primary spermatocytes, round spermatids, elongated spermatids and 
spermatozoa (Fig. 31A). However, in mutant testes 2 months after TAM treatment 
spermatogenesis was completely arrested. In seminiferous tubules, one could find only 
Sertoli cells which fill out the whole lumen. Tubules were reduced in size, so it caused 
increase of Leydig cells number (Fig. 31B).  
This phenotype appears already in mutant testes 2 weeks after TAM treatment (at the 









Figure 31. H&E staining of testes isolated from Pelo∆/∆CreERT and wild- type mice. 
A – wild type; B – mutant. Abbreviations: L – Leydig cells; S – spermatogonia; Ps – primary 
spermatocytes; Rs – round spermatids; Es – elongated sp rmatids; Z – spermatozoa; Se – 
Sertoli cells. Photos were taken under 20 x magnification. 
 
A piece of bare skin from neck area was isolated and stained with H&E. In wild type, 
the epidermis is relatively thin in comparison to dermis (Fig. 32A). Epidermis consists of 
keratinocytes – cells which are arranged in 5 layers. The most outer layers are composed of  
flattened cells which have no nuclei. However, in the skin of the mutant we could observe 



















Figure 32. Disorders observed in Pelo∆/-CreERT skin structure 
Skin was isolated from control (A) and Pelo∆/-CreERT mouse (B). Hf – hair follicle (A); E – 
epidermis; D – dermis; A – adipocytes(A); In – inflammatory region(B); P – 
parakeratosis(B); H – hyperkeratosis(B). 
 
from outer layer were found to possess nuclei (parakeratosis) – this process is 















symptoms of a chronic inflammatory response appear in deeper layers of the skin. 
Histological studies of kidney also revealed lymphocyte-rich inflammatory cell infiltration 
(data not shown).  
Other tissues of the mutant mice (such as spleen, liver, stomach, heart, intestine, 
ovary) were also studied, but they did not display such a pronounced phenotype. The effect 
of pelota deletion on different organs still requires thorough studies. The impaired 
development of thymus beside these histological  observations implies putative defects in 
the immune system of Pelo∆/∆ mice. 
The thymus is an organ where thymocytes mature into T cells, which respond to 
foreign antigens, but do not recognize self-antigens (Goldrath and Bevan, 1999; Miller, 2002; 
Starr et al., 2003). We suspected that pelota depletion affects the maturation of T cells. 
Therefore, we have analyzed cell surface markers for B and T cells isolated from thymus 
(Table 4.) and spleen (Table 5.) of mutants (n=4) and controls (n=4) using flow cytometry. 
The thymus and spleen cells were prepared and stained with fluorescence-conjugated 
monoclonal antibodies, which recognize different cell surface markers (Materials & 
methods, 2.2.17.). The analyzed cell number was 11±4 x 107 for control thymus and 11±5 x 
107 for control spleen. The amount of mutant cells wasreduced to 0.8±0.7 x 107 in thymus, 
and 5.5±2.5 x 107 in spleen.  
We have found a strongly reduced level of CD4+CD8+ double positive, CD4+CD8-, 
CD8+CD4- single positive and CD3-positive cells (T lymphocytes). The number of double-
negative (CD4-CD8-) cells, i.e. thymocyte progenitors derived from hematopoietic stem cells, 
was 6-fold increased in all mutants. It is extremely noticeable in mutant 2’ (Table 4.), where 
these cells constituted a vast majority of tested cell population. The decrease of 
differentiating and mature stages of T cells indicate that after Pelota protein is deleted, the 
further differentiation of thymocytes is disrupted and the stage of double negative cells is 















Table 4. The number of T cells (various developmental stages) in thymus of TAM-treated 
animals (Pelo∆/∆ CreERT and Pelo∆/- CreERT) 
The animals treated with TAM at the age of 6 weeks were analysed 1 month after treatment. 
The mice which were injected at the age of 15 days, were examined 2 weeks after treatment. 
The thymus of mutant 3’ was strongly reduced and the amount of isolated cells was 
insufficient for FACS analysis. 
 
Organ THYMUS 
6 weeks 15 days 
                              Age of treated mice 
Cell surface marker Control Mutant Control 
Mutant 
1’          2’ 
DN (double-negative CD4-CD8- cells) 4.78 30.59 11.1±0.6 15.46 98.83 
CD4+CD8+ (differentiating thymocytes) 76.71 34.86 60.5±1.6 77.67 0.64 
CD4+CD8- SP 
(differentiating thymocytes) 
11.91 28.11 16.94±0.06 2.75 0.18 
CD8+CD4- SP 
(differentiating thymocytes) 
5.41 3.39 11.3±1 4.06 0 
CD3+ (T cells) 18.08 11.19 31.81±6.2 7.19 0.56 
 
Examination of B cells derived from spleen demonstrated that CD19- and B220-
positive cells (B lymphocytes) in Pelo∆/-CreERT animals are also reduced in number (Table 
5.) as compared to the controls. CD19 and B220 (CD45) are cell surface markers specific for 
mature B cells. In some mutant mice we have found a slight increase in number of 
CD4+CD25+ cells, which recognize autoantigens. This might suggest that mice exhibit 
autoimmune disorder, but it requires further studies. We detected higher number of CD25+ 
cells, which are indicators of inflammatory state of the organism as well as NK cells (DX+-
positive), which were increased. The amount of T cells, detected in spleen, was variable 




















Table 5. The number of B and T cells in spleen of TAM-treated animals 
The animals treated with TAM at the age of 6 weeks were analysed 1 month after treatment. 
The mice which were injected at the age of 15 days, were examined 2 weeks after treatment. 
NK cells - natural killer cells. 
 
Organ SPLEEN 
6 weeks 15 days                      Age of treated mice 
Cell surface marker 
Control Mutant Control 
1          2         3 
Mutant 
1’        2’        3’ 
CD19+ (B cells) 39.09 11.7 30.1±14.1 5.03 7.72 12.35 
B220+ (B cells) 44.7 22.85 33±5 11.61 9.05 18.67 
MHCII + (B cells) 0.12 0.26 2.4±2.2 1.68 1.3 0.3 
CD25+ (activated B and T cells) 0.72 1.46 1.5±0.3 0.87 1.45 1.2 
CD4+CD25+ 0.69 1.51 1.3±0.6 0.91 1.37 0.88 
DX5+ (NK cells) 2.79 6.68 3.1±0.9 3.18 1 2.39 
CD3+ (T cells) 32.29 9.99 17.3±18 5.71 6.99 20.74 
CD4+ (T cells) 35.07 49.53 22.8±16 12.6 11.9 18.45 
CD8+ (T cells) 14.77 13.43 13.7±10.2 3.51 4.61 6.68 
 
 
3.1.8. Pelota-deficient ESC line – functional characterization 
 
 To study pelota function on a molecular level, we generated a ESC line with flox 
allele and tamoxifen-activated CreERT recombinase. For all experiments described we used 
PeloF/F cells treated with OHT as a control. 
To study if pelota deficiency enhances direction of cells to programmed cell death, 
we performed the annexin-7AAD assay. For control, we used PeloF/- cells either untreated or 
treated with OHT and untreated mutant cells (PeloF/-CreERT). Using FACS analysis, we 
examined early (annexin V staining) and late (7-AAD staining) apoptosis levels in the 
culture (Fig. 33). The percentage of viable cells (NOT STAINED, Fig. 33) was predominant 
in comparison to apoptotic cells. The experiment showed that the number of either dead or 
apoptotic cells was not increased upon pelota deletion. It demonstrates that pelota deficiency 






























Figure 33. Flow cytometric analysis of apoptosis level in mutant cells treated with OHT 
and untreated 
FITC-Annexin V/7AAD flow cytometry of an untreated control (A) and mutant (C). OHT-
treated cells  are presented in B (control) and D (mutant). The lower left quadrant shows 
viable cells, which exclude 7AAD and are negative for FITC-Annexin V binding. The upper 
right quadrant contains the nonviable necrotic cells positive for 7AAD and annexin binding. 
The lower right quadrant represents the apoptotic cells, FITC-Annexin V positive and 7AAD 
negative, demonstrating cytoplasmic membrane integrity. The graph (F) indicates 
percentage of all kinds of cells. NOT STAINED - viable cells; 7AAD  – single-stained with 
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7AAD (necrotic cells); ANN – single-stained with annexin (apoptotic cells);  ANN+7AAD - 
double-stained with annexin and 7AAD. 
 
Lack of prominent effect of pelota ablation on proliferation and viability of ESCs led 
us to check the role of pelota protein in differentiation. Therefore, the cells were cultured in 
conditions that induce the differentiation process. ESCs were trypsinized, plated on bacteria 
dishes and left in suspension in the absence of LIF for 10 days. Under these conditions  ES 
cells aggregated and formed embryoid bodies (EBs), in which cells differentiated into the 
three germ layers – endoderm, mesoderm and ectoderm. We did not observe any differences 
in morphology between mutant and control cells. EBs were thereafter trypsinized, plated on 
gelatin-coated dishes and cultured in ESC medium without LIF. We could observe a striking 
difference in morphology between mutant and control ce ls. The control cells were 
differentiated, whereas pelota-deficient cells formed two types of cells spread on the plate: 
differentiated ones attached to the bottom and ESC-like colonies growing over them. To 
confirm pluripotent character of the mutant cells, we stained them with alkaline phosphatase 
(AP), which is an enzyme specific for pluripotent cells. Pelo∆/-CreERT colonies were AP-
positive (Fig. 34B). 
 
Figure 34. Alkaline phosphatase staining of replated EB-like structures from Pelo∆/-
CreERT and wild-type cells. 
EBs after 10 days of differentiation were trypsinized and plated on gelatine. A – wild type; B 
– mutant cells. 
 
 Further confirmation of pluripotent nature of mutant EBs was determined by 
expression analysis of essential molecular marker for pluripotency – Oct4 gene, which is 
downregulated as soon as the cell begins to differentiat . Western blot analysis showed that 
Oct4 protein is normally expressed in undifferentiated cells (ES1 and ES9), but it was also 







Figure 35. Western blot analysis of Oct4 expression n differentiated and undifferentiated  
cKO/CreERT cells. 
Picture shows Oct4 protein in undifferentiated mutant (ES9) and control (ES1) cells; 
differentiated mutant (EB9) and control (EB1) cells. 
 
 For further demonstration of Oct4 expression in Pelo∆/- EBs, we  performed 
immunohistochemical staining of EBs, which were cultured for 18 days in medium without 
LIF. The experiment proved that Oct4 protein was still expressed in the mutant  cells (Fig. 
36). Nonetheless, we could find few positive cells alo in the control (Table 6). There were 
21.2% of positive and partially positive cells in the control type, whereas in the mutant such 
colonies constituted 45.9% of all counted colonies.  These data show that Pelo∆/- cells failed 











Figure 36. Immunohistochemical analysis of Oct4 expression in differentiated mutant 
cells 
The cells were cultured for 18 days without LIF and then stained with antiOct4 antibody and 
mounted in medium containing DAPI. A, C, E –control cel s; B, D, F – mutant cells. The 
















Table 6. Statistcs for Oct4-positive cells after differentiation. 
Cells were plated on 4-chamber slides. The calculations are done for each chamber of the 
slides with control and mutant cells. 
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 We have then examined the expression of miR-290 cluster – set of microRNAs 
specifically expressed in pluripotent cells. In wild-type cells, miR-290 was downregulated 
upon differentiation and loss of pluripotency. However, in pelota-deficient EBs the amount 






















Values represent relative levels of microRNAs of miR-290 cluster in undifferentiated  
control (ES1) and mutant (ES9) ES cell and differentiated cells: the control (EB1) and the 
mutant (EB9). Expression levels were normalised to the expression of endogenous control 
(Sdha). 2 technical replicates were done for each microRNA and each cell type. The 
different colours of bars stand for different microRNAs of miR-290 cluster – explained in the 
right table. 
 
 Results presented above, indicate that the mutant EBs are indeed pluripotent and 
their differentiation is somehow disrupted. To shed  more light on differentiation process in 
Pelo∆/-CreERT cells, we determined the potential of mutant ESCs for neuronal 
differentiation (Fig. 38). The experiment did not show any difference betwen mutant and 
control cells in their ability to form neurons. In both cases one could observe neuronal cells 
which were confirmed by immunohistochemical staining with neuron-specific markers – β3-
tubulin (TUJ) and tyrosine hydroxylase (TH). As shown in Figure 38, TUJ- and TH-positive 
cells were found in both cell lines. However, the number of mutant cells, which formed 
neurons seems to be decreased in comparison to control. 
 
 
Figure 38. Neural differentiation of mutant and control cells. 
The control (A,B) and mutant (C,D) cells were stained with two neuron-specific antibodies: 
















 For investigation of endodermal and mesodermal differentiation ability of mutant 
cells, we determined the expression level of early nd late molecular markers for mesoderm 
and endoderm development. Eomesodermin is expressed early during mesodermal 
differentiation (Izumi et al. 2007), whereas vimentin is suggested to be neccesary in 
advanced stages of mesoderm formation (Rius and Aller, 1992). The expression level of 
eomesodermin  was higher in 10-day-old Pelo∆/-CreERT EBs than in control EBs (Fig. 39A), 
whereas the vimentin was expressed in mutant EBs on a very low level in contrast to the 
control (Fig. 39B). The data suggest that mesoderm formation is arrested at early stages in 
Pelo∆/-CreERT cells. The high expression of vimentin in cotr l EBs suggests that the cells 
have reached the late stage of mesodermal differentiatio , while in the mutant cells the 
expression of vimentin has not yet been activated due to early-stage arrest. To verify this 









































Figure 39. Eexpression profiles of early (A) and late (B) mesodermal markers. 
Values represent relative level of eomesodermin and vimentin in 10-day-old mutant (EB9) 






and control (EB1) ES cells. Expression levels were normalised to the expression of 
endogenous control (Sdha). 2 biological replicates were done for each cell type. 
 
 
 Sox7 and Hnf4 are expressed at early and late stages of ndodermal differentiation, 
respectively (Futaki et al., 2004; Duncan et al., 1997). The expression analysis of these 
markers in 10-day-old EBs revealed that Sox7 expression level does not differ significantly 
between Pelo∆/-CreERT and control EBs and is similar to the level in undifferentiated cells 
(Fig. 40A). Late endodermal marker (Hnf4) exhibits high exprssion level in 10-day-old 











































Figure 40. Eexpression profiles of early (A) and late (B) endodermal markers. 
Values represent relative level of Sox7 and Hnf4 in 10-day-old mutant (EB9) and control 
(EB1) EBs and was compared to the expression in undifferentiated mutant (EB9) and 
control (EB1) ES cells. Expression levels were normalised to the expression of endogenous 
control (Sdha). 2 biological replicates were done for each cell type. 
 
 of Hnf4 transcript is reduced to the level detected in undifferentiated cells. The data 






from progression to later stages of differentiation, whereas downregulation of Hnf4 may be 
due to arrest in middle stages of endoderm formation. To evaluate this hypothesis, the 
expression level of both markers must be done in 3-, 5- and 10-day-old embryoid bodies. 
 
3.2. Transgenic mice overexpressing Pelota 
 
 An alternaltive way for demonstration of pelota function in germ cells is a transgenic 
mouse model. In reference to pelota studies in Drosophila ovary (Xi et al., 2005), where 
depletion of pelota was found to cause loss of self-renewal of germ cells, we suspected that 
spermatogenesis in mouse testis could be affected as well. 
To examine this hypothesis, we studied the phenotype of pelota transgenic animals 
which had been generated in the institute (Buyandelger, 2006). We analyzed four transgenic 
lines - two Adam lines (1 and 9) and two Eva lines (1 and 6). 
A pelota transgenic allele in Adam lines contains human pelota cDNA under 
ubiquitin C promoter. The transgene (PeloT) is specifically expressed in testes (Buyandelger, 
2006). 
Eva lines possess a transgenic allele composed of human pelota cDNA under the 
control of the elongation factor 1α promoter. EvaL1 line was shown to exhibit testis-specific 
PeloT, whereas the expression of PeloT in EvaL6 was detected in all studied tissues 
(Buyandelger, 2006). It was impossible to analyze the expression pattern of the transgene on 
protein level, because transgenic PELO protein did not possess any epitope tag (e.g. c-myc) 
and was therefore undistinguishable from endogenous Pelota protein. Therefore, the studies 
concerning expression were done on the level of RNA. 
 
3.2.1. Testis-specific transgenic lines 
 
 Despite different promoters in Adam and Eva lines, the mice of lines AdamL1, 
AdamL9 and EvaL1 showed transgene expression restricted to testes. Fertility of males in 
all lines was not affected, i.e. the mice gave viable offsprings and avarage litter size was 
comparable to wild type FVB strain: 9±2 animals. We d cided to generate lines of 
homozygous PeloT mice. To establish homozygous lines (PeloT/T), we mated PeloT mice 
from F1 generation together. Subsequently, F2 mice were bred with wild type in order to 





Figure 41. Scheme of test breedings to identify the omozygous and hemizygous 
transgenic mice. 
Pelopos stands for mouse that is positive for transgene, whereas Pelo+/+  is a wild type 
without transgene. Such genotype estimation was done on the basis of at least 2 litters for 
each positive mouse. 
 
We were able to establish homozygous lines for AdamL1 and AdamL9, whereas test 
breedings did not reveal any PeloT/T mouse of line EvaL1. Histological analysis of testes 
isolated from F2 animals of all those three lines dmonstrated that pelota overexpression did 
not influence spermatogenesis in any of the lines (Fig. 42). We detected all spermatogenic 
stages in seminiferous tubules of AdamL1, AdamL9 and EvaL1 animals. 
Pelopos   x  Pelo+/+ 
F1: PeloT only 
Pelopos = PeloT/T 
Pelopos = PeloT 
F1: PeloT ; Pelo+/+ 







Figure 42. H&E staining of adult testes isolated from AdamL1, AdamL9 and EvaL1. 
Sp – spermatogonia; Ps – pachytene spermatocytes; Rs – round spermatids; Z – 



























 The absence of PeloT/T mice in F2 generation of EvaL1 line led us to assume that the 
insertion of transgenic allele in the genome might have disrupted a gene, which plays a 
crucial role during embryogenesis. To determine the int gration site of the transgene in 
EvaL1 genome, we used GenomeWalker Kit (Materials & methods, 2.2.3), which allowed 
us to identify the genomic sequence adjacent to 3’end of transgenic pelota allele. It turned 
out that pelota construct was recombined into the intronic region of Ror1 (receptor tyrosine 
kinase-like orphan receptor 1) gene located on chromos me 4. We were able to define the 
exact integration site of 3’ end of the construct. To confirm the integration site, three primers 
were designed (Fig. 43). Two of them were located around the integration site and one was 
located on 3’end of transgenic construct. The set of these primers was used for genotyping 
of EvaL1 animals.  
 
Figure 43. Scheme of pelota construct integration site 
The figure presents integration of pelota transgenic allele (EF1_pelota) in the sequence of 
Ror1 gene, in the intron 3. The arrows show primers which are used for genotyping of 





 The PCR assay performed by means of designed primers confirmed that 
determination of integration site was correct. We obtained the expected bands either for 
wild-type allele or for introduced transgenic allele (Fig. 44). It demonstrates that all 
offsprings obtained from breedings between transgenic mice, were wild-type or 
heterozygous. Neither of them was PeloT/T.  








Figure 44. Genotyping PCR for integration site in EvaL1 line 
Wild-type band stands for intron 3 frogment of Ror1 gene without pelota construct 
integration amplified by F1 and R primers (Fig. 43), while transgenic allele is amplified by 
F2 and R.. 
 
To determine whether the PeloT/T mice die during embryogenesis, we genotyped embryos at 
E15.5 and E17.5 stages. We found PeloT/T mice in both stages. Analysis of neonatal 
offsprings derived from crosses of heterozygous PeloT mice revealed that PeloT/T newborns 
died within 24 hour after birth (Table 7.). 
 
Table 7. Genotype statistics of newborns which died within 24 hours after birth. 
Parents genotype PeloT                          x                        PeloT 
Newborns genotype Pelo-/- PeloT PeloT/T 
No. of newborns 17 28 14 
No. of newborns 
which died within 
24h 
1 5 14 
 
 It could be possible that during recombination process a part of intron/exon sequence 
was deleted and Ror1 was disrupted. To prove this hypot esis, Western analysis of proteins 
isolated from kidneys of PeloT/T, PeloT and Pelo-/- embryos was performed using polyclonal 
anti-ROR1 antibody. As shown in Figure 45., the ROR1-specific 105 kDa band was 
detected. The protein was present either in wild-type or in PeloT kidney-protein extracts, 









Figure 45. Western analysis for ROR1 protein in EvaL1 mice. 
The upper photo presents staining with anti-ROR1 antibody which detects the ROR1 protein 
in size of 105 kDa. Antibody staining with anti-tubulin (lower photo) demonstrates tubulin 
protein of 51 kDa which characterizes the quality of proteins used for ROR1 staining. 
 
 Lack of ROR1 protein confirmed accidental disruption of this gene by recombination 
of pelota transgene into Ror1 locus. Ror1 knockout phenotype was published (Nomi et al., 
2001). It was reported that Ror1-/- newborns had respiratory problems and died within 24 
hours after birth. After observation of EvaL1 newborns, we obtained convergent results. 
 
3.2.2. EvaL6 as a rescue for pelota knockout mice 
 
To study the consequence of Pelo-overexpression on embryonic and germ cell 
development, our group generated a transgenic mouse line that ubiquitously overexpressed 
Pelota protein. EvaL6 line was generated by the introduction of the transgenic pelota under 
EF1 promoter into the wild-type mouse genome (Buyandelger, 2006). The ubiquitous 
expression of PeloT in EvaL6 mice did not influence mouse viability and fertilty. We 
generated a homozygous EvaL6 line like described above (Fig. 41). The line did not exhibit 
any apparent phenotype.  
These transgenic animals were used to solve the question whether the embryonic 
lethality of Pelo-deficient mice is due to inactivaon of pelota gene or because of position 
effect resulting from manipulation of pelota locus and consequent change in expression of 
neighbouring genes.  
To verify these possibilities, we introduced the transgenic Pelo allele into the genome 









Figure 46. Strategy of breeding for generation of rescue mouse 
 
Generated Pelo-/-PeloT rescue mice are healthy (Fig. 47) what provides evidence that 
pelota transgenic allele is properly constructed. Moreover, its expression under EF1 
promoter is efficient to substitute endogenous Pelota protein and mimic its function in living 












Figure 47. Rescue mouse: Pelo-/-PeloT male 
 
Table 8 demonstrates the genotype statistics of breedings between Pelo+/-T mice, 
which yielded Pelo-/-T mice. All rescue mice were viable. Their fertility was studied in test 
breedings. One Pelo-/-T female has already delivered 8 offsprings, while no pr geny was 
obtained from any Pelo-/-T male within 2-month breedings. It indicates that tr nsgenic Pelota 
protein is also capable of retaining germ cell differentiation and functionality at least in 
ovaries. 
 
 Pelo+/-     x          PeloT/T 
 
F1: Pelo+/-T       x          Pelo+/-T 
 




Table 8. Statistical frequency of expected genotypes derived from breedings producing 
rescue mice  
 
Pelo+/-T  x   Pelo+/-T 
F1 generation +/+ +/- -/- +/+T +/-T -/-T 
Mendelian ratio 1 1 1 1 1 1 































4.1. Brief overview of the results 
 
In 2003 pelota function was analyzed in pelota knocout mouse (Adham et al., 2003). 
The phenotype of homozygous mutants (Pelo-/-) is lethal during early stages of 
embryogenesis (E7.5). Pelo-/- blastocysts fail to expand in growth after 4-day culture. It was 
hypothesized that inner cell mass displays the defect rather in cell proliferation than in 
differentiation. The putative role of pelota in differentiation was demonstrated in Drosophila 
ovary, where it is involved in self-renewal of germ stem cells (Xi et al., 2005). 
To investigate the function of murine PELO in cell cycle/differentiation, we 
generated a conditional knockout mouse. On the level of RNA, we demonstrated that 
tamoxifen-induced recombination of floxed Pelo allele was complete in generated PeloF/-
CreERT ESC line (Fig. 11). The procedure was also very efficient in the mouse model, 
where we detected almost complete deletion of the floxed allele (Fig. 29).  
The histological analysis showed that spermatogenesis was completely disrupted - all 
stages of germ cells were absent, only Sertoli cells could be found (Fig. 31). For evaluation 
of PELO effect on spermatogenesis progression, we gen rated testis-specific knockout mice 
(PeloF/-Stra8-Cre), where deletion of floxed Pelo region occurs in accordance with Stra8 
promoter-derived Cre recombinase expression (chapter 3.1.6.)  The immunohistochemical 
analysis of mutant testes unveiled lack of spermatogenic progression since day 15, when 
meiotic division starts. The quantitative analysis of premeiotic markers revealed that 
expression of Stra8, Dazl and Ddx4 in 10-day-old testes was alike – all three markers 
exhibited a drastic increase of transcript level at th  time in the control, but in mutant testes 
we observed twofold reduction (Fig. 25, 26, chapter 3.1.6.4.). In case of Plzf, Sox3 and c-
Kit, there was no dramatic discrepancy between control and mutant, despite the slight 
reduction at day 5. It indicates that there was no clear effect of PELO depletion at the stage 
of either undifferentiated (Plzf and Sox3) or differentiated (c-Kit) spermatogonia. It suggests 
that the phenotype appeared with onset of spermatogonial differentiation, that is with entry 
to meiotic division. In addition, we found mosaic mice (PeloF/∆/-Stra8-Cre), which displayed 
incomplete Pelo allele recombination in various somatic tissues, including kidney, liver, 
heart, spleen, lungs. It indicates that Stra8 expression is transactivated early in 
embryogenesis. However, we did not find Pelo∆/-Stra8-Cre mice, what means that this 
genotype is lethal during embryogenesis, similar to pel ta classical knockout.  
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Handling the well-functioning conditional knockout mouse model, we were able to 
verify why Pelo null blastocysts were unable to produce the ESC line. We generated PeloF/-
CreERT ESC line, where we successfully deleted Pelo (the cell genotype become Pelo∆/-
CreERT) by CreERT recombination (Fig. 10). The null cells did not show any proliferative 
disorder and were well preserved in culture. They also did not exhibit an increased level of 
programmed cell death. Therefore, we analyzed the diff rentiation capability of mutant ES 
cells. The Pelo∆/-CreERT ES cells turned out to be defective in generating embryoid body 
structures. The cells showed sustained Oct4 expression and upregulated expression of miR-
290 cluster – family of microRNA which is characteristic for pluripotent ES cells (Houbaviy 
et al., 2003, 2005). To investigate in which germ layer the differentiation failure occurs, we 
used the mutant cells for neuronal differentiation. The experiment resulted in differentiation 
of neuronal cells in vitro. This indicates that the process of generating ectod rm is 
unaffected (Fig. 38). For analysis of mesoderm and endoderm lineages, w  performed 
quantitative RT PCR by means of early and late markers for both germ layers. In mutant 
cells subjected to EB formation, the level of early mesodermal marker (eomesoderin, Fig. 
39A) was significantly higher that in control EBs, and expression of a late marker (vimentin, 
Fig. 39B) was strongly reduced. Whereas the early marker for endodermal development 
(Sox7) did not show any difference between mutant and control, the late marker (Hnf4) was 
drastically downregulated in mutant cells. From these results we assume that pelota-
deficient cells are defective in mesoderm and endoderm formation. To prove our hypothesis 
we studied differentiation of adult stem cells, i.e. hematopoietic stem cells and 
spermatogonial stem cells, which are convenient models in the mouse due to continuous 
differentiation process along the life span of the animal and due to their mesodermal origin. 
The analysis of B and T cells isolated from spleen and thymus demonstrated the 
reduction in number of both kinds of cells. Additionally, in case of T cells we detected a 
strong increase of double negative cells (CD4-CD8-), which are developmental precursors of 
mature T cells. However, the following developmental stages, that are double positive 
(CD4+CD8+), single positive (CD4+CD8- or CD8+CD4-) and mature T cells (CD3+) were 
reduced in number (Table 4.). This clearly shows the developmental arrest of T cells. 
However, proliferation of precursor cells was not affected. 
To show that mortality of classical knockout mice results from pelota inactivation, 
we crossed Pelo+/- mice with transgenic PeloT mice (chapter 3.2.2), which rescued the lethal 
phenotype. It clearly demonstrates that the lethality originated from pelota inactivation, and 
it was not the position effect after introduction of the allele into the genome. 
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In addition, we analyzed transgenic mice which overexp ess PELO in testis-specific  
manner. However, we did not detect any disorder in spermatogenesis. The mice were fertile. 
This can suggest that PELO protein is subjected to accurate posttranslational regulation in 
the cell and the excessive amounts of the protein ar  removed.  
 
4.2. Embryonic stem cell fate shift from pluripotent to differentiated state 
 
Embryonic stem cells are derived from the inner cell mass of the blastocyst (E3.5 in 
murine embryogenesis) and are capable of giving rise to all three germ layers, what 
constitutes  their pluripotency. The important feature of ES cells is their ability to self-renew, 
which requires a complex transcriptional profile (Zhou et al., 2006). Some factors were 
identified to contribute  to the pluripotency mainte ance, including Oct4, Sox2 and Nanog. 
The shift of the cell fate to differentiation causes downregulation of the pluripotent markers. 
For instance, in the cells induced to mesoderm formation, Oct4 is not expressed (Yeom et al., 
1996; Yoshimizu et al., 1999).Depletion of the main pluripotent markers stands for the loss 
of pluripotency. Oct-4-deficient embryos die at blastocyst stage due to loss of pluripotent 
cells composing inner cell mass (Nichols et al., 1998; Niwa et al. 2000). Sox2-targeted 
deletion causes a lethal phenotype at peri-implantatio  stage of embryogenesis. In contrast 
to Oct4-null mutants, Sox2-/- embryos develop the inner cell mass, but they fail to maintain 
epiblast cells which are essential for further differentiation of extraembryonic tissues 
(Avilion et al., 2003). Nanog-deficient ES cells differentiate into extraembryonic endoderm 
lineage, losing pluripotency (Mitsui et al., 2003). Preservation of pluripotency requires also 
silencing of genes which are responsible for differentiation initiation. Such inactivation is 
implemented by means of epigenetic regulation, i.e.chromatin remodeling, histone 
modifications and DNA methylation (Boyer et al., 2006; Lee et al., 2006). However, the 
genes of pluripotent markers are also subjected to epigenetic regulation. Such regulation by 
methylation was reported for Oct4 (Hattori et al., 2004) and Nanog promoters (Deb-Rinker 
et al., 2005). It was unveiled that Nucleosome Remodeling and histone Deacetylation 
(NuRD) complex (Xue et al., 1998) is recruited at promoter sequences of the pluripotent 
markers and is responsible for epigenetic modificatons and silencing of the gene expression 
(Wade et al., 1999; Lan et al., 2002; Crook et al., 2006; Kaji et al., 2006).  
The NuRD complex is composed of methyl-binding-domain-related protein 2 and 3 
(MBD2/3), histone-binding proteins, chromatin remodeling ATPases, zinc-fingers proteins 
and histone deacetylases, which form together orchestrat d apparatus for epigenetic 
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modifications (Crook et al., 2006). MBD2 and 3 were id ntified as core components of 
NuRD complex (Ng et al., 1999; Zhang et al., 1999). However, it was found that they are 
mutually exclusive. They reside in two NuRD complexes with distinct core-subunit 
compositions: MBD2/NuRD and MBD3/NuRD (Le Guezennec et al., 2006). The results of  
knockout studies for MBD2 and MBD3 indicate that they play nonoverlapping roles in 
mouse development. Deletion of MBD2 results in relatively mild defects in transcriptional 
silencing of methylated promoters. The MBD2-knockout mice are viable – this demonstrates 
that MBD2 is not crucial  for mouse development. Unlike MBD2, the deletion of MBD3 
causes embryonic lethality (Hendrich et al., 2001).  
Due to the fact that it was impossible to establish an ES cell line from Mbd3-/- 
blastocysts, Kaji et al. (2006) generated an ESC line with floxed Mbd3F/- allele. After MBD3 
deletion, the mutant ES cells were unable to repress transcription of Pramel6 and Pramel7 – 
genes highly expressed in preimplantation stages, and Dppa3 which is an early marker of 
primordial germ cells. When the Mbd3-/- ES cells were subjected to differentiation 
conditions, they displayed persistent expression of pluripotent markers (Oct4, Nanog, Rex1). 
In addition, they failed to express differentiation markers for all developmental lineages 
(endoderm, mesoderm and ectoderm), except for primitive ectoderm marker Fgf5 at day 3 of 
differentiation. However, the cells were unable to downregulate the Fgf5 expression at later 
stages of differentiation as compared with control ce ls. This suggests that ectodermal 
differentiation can start, but is arrested at early stage (Kaji et al., 2006). Our results 
demonstrate that PELO protein inactivation leads to analogous phenotype.  
Similarly to Mbd3-/-, Pelo∆/- ES cells stay pluripotent in differentiation conditions, 
what was confirmed by alkaline phosphatase staining a d sustained Oct4 expression. 
Analysis of differentiation markers shows that Pelo∆/- and Mbd3-/- ES cells subjected to 
embryoid body formation exhibit a differentiation arrest in either all developmental lineages 
(Mbd3-/-) or mesoderm and endoderm (Pelo∆/-). Interestingly, both mutant cell lines seem to 
display primitive cell fate shift to differentiation into one germ layer: ectoderm (Mbd3-/-) or 
mesoderm (Pelo∆/-). However, the increased mRNA levels of early differentiation markers 
and decreased transcript levels of late differentiation markers lead us to the assumption that 
further formation of ectoderm (Mbd3-/-) and mesoderm (Pelo∆/-) is arrested at an early stage 
of differentiation. This convergent phenotypes suggest that the defect of differentiation 
capacities of Pelo∆/- ES cells may result from malfunction of NuRD complex in methylation 
of Oct4 promoter, which in these cells is constantly active under differentiation conditions.  
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 This hypothesis is supported by the fact, that pelota was found to interact with 
CDK2AP1 protein (unpublished data), which is also required for epigenetic silencing of the 
Oct4 gene during ESC differentiation (Deshpande et al., 2008). In addition, the protein was 
identified as a core component of MBD2/NuRD and MBD3/NuRD complexes (Le 
Guezennec et al., 2006). Deletion of Cdk2AP1 results in early embryonic lethality and 
sustained expression of Nanog and Oct4. As these findings are convergent with the Mbd3-
deficiency phenotype, it was assumed that CDK2AP1/MBD3/NuRD complex is responsible 
for silencing of genes of pluripotent markers during the differentiation process (Deshpande 
et al., 2008). Due to the fact that PELO protein is localized in the cytoplasm and not in the 
nucleus, the interaction between CDK2AP1 and PELO may have a regulatory impact on 
signalling pathways related to promotion of differentiation, like the transforming growth 
factor β  (TGF-β) pathway. 
 
4.3. Signal transduction in differentiation and pluripotency  
 
 The development and homeostasis of most mouse tissues are controlled by the TGFβ 
signal transduction network, which involves distinc receptor families and mediator proteins 
activating target gene transcription in association with DNA-binding proteins (Massague, 
1998). The TGF-β family consists of polypeptide growth factors, which regulate various 
developmental processes, such as cell proliferation, l neage determination, differentiation 
and cell death. The TGF-β is also an important antiproliferative factor during early stages of 
oncogenesis (Hill et al., 2009). 
 The TGF-β1 is a member  of the TGF-β family. It is a cytokine, which exerts 
suppressive effects on epithelial, endothelial and hematopoietic cells by promoting synthesis 
of cyclin-dependent kinase inhibitory proteins (Mass gue, 1990; Hannon and Beach, 1994; 
Alexandrow and Moses, 1995; Polyak, 1996). Hu et al. (2004) demonstrated that this growth 
factor leads to induction of CDK2AP1 transcription a d in consequence to increased 
CDK2AP1 association with CDK2. The interaction results in negative regulation of CDK2 
activity, i.e. proliferation inhibition. This TGF-β mediated growth suppression is affected by 
CDK2AP1 depletion. From these data we can assume that CDK2AP1 protein, a core 
component of MBD3/NuRD complex, is activated by TGF-β. As it is doubtful that PELO 
participates directly in the NuRD complex formation, we suppose that disruption of Oct4 
promoter methylation in Pelo-deficient ES cells is an effect of upstream deregulation of 
TGF-β signalling pathway, which controls pluripotent gene expression by epigenetic 
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silencing and hence differentiation of mouse ES cells. It is probable that PELO/CDK2AP1 
interaction plays a role in TGF-β promotion (Fig.49). 
 An alternative pathway, which may be deregulated in pelota-deleted Pelo∆/-CreERT 
ES cells is the LIF signalling pathway. LIF signalling inhibits mesoderm and endoderm 
formation, whereas ectoderm formation in ESCs is blocked by bone morphogenetic protein 
4 (BMP4) signalling (Ying et al., 2003). Due to the fact that ectoderm differentiation upon 
pelota inactivation is unaffected, we assume that BMP4 pathway is not influenced by PELO 
protein. In normal ES cells, LIF application leads to phosphorylation of distinct factors, 
including STAT3, a signal transducer and activator of transcription 3 (Boeuf et al., 1997), 
what leads to maintenance of pluripotent state. Inactiv tion of STAT3 was reported to 
induce spontanous differentiation (Paling et al., 2004). The studies concerning STAT3 
expression revealed that this factor, activated under differentiation conditions, is capable of 
sustaining self-renewal of ESCs without addition of LIF (Matsuda et al., 1999). The STAT3-
dependent pathway is poorly understood, but it is known that c-myc and Eed genes (cell 
proliferation propagators) are direct targets of STAT3 (Cartwright et al., 2005; Ura et al., 
2008). Recently, 58 genes were identified as target genes of STAT3 (Bourillot et al., 2009). 
Some of them, like Smad7 or c-myc, are negative regulators of TGF-β signalling (Hayashi et 
al., 1997; Imamura et al., 1997; Nakao et al., 1997; Feng et al., 2002).  
 STAT3 pathway sustains pluripotent character of ES cells by inhibiting mesodermal 
and endodermal differentiation processes activated by TGF- β signals. Pelota function may 
be associated with downregulation of STAT3 signallig. In Pelo∆/-CreERT cells subjected to 
differentiation conditions, mesoderm and endoderm ae not formed, as it is shown on the 
transcript levels of lineage-specific markers (Fig. 39, 40). It might be connected with 
uncontrolled upregulation of STAT3, which is able to maintain pluripotency in the absence 
of LIF. However, the studies in Xenopus embryos have shown that STAT3 can also promote 
mesoderm formation (Ohkawara et al., 2004). In different conditions, namely various sorts 
and doses of signals, STAT3 can become also up- or downregulated by BMP2, a TGF-β 
family member, what in consequence leads to apoptosis or differentiation (Kawamura et al., 
2000; Rajasingh et al., 2007). TGF-β and STAT3 signalling pathways form a dynamically 
balanced network which decides about the fate of the cell depending from incoming signals. 
Therefore, a putative function of PELO in negative regulation of STAT3 must be well 
adjusted to the signal influx. 
The TGF-β is also a regulator of immune response. It was report d to induce CD8 
expression in CD4-CD8- double negative thymocyte precursors during T cell differentiation 
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process (Suda and Zlotnik, 1991; 1992; Inge et al., 1992; Plum et al., 1995).  The maturation 
of B cells is also controlled by TGF-β, which positively and negatively regulates the 
expression of cell surface markers in B cell precursors and mature B cells (Stavnezer, 1996). 
In activated B cells, TGF-β inhibits cell proliferation and may induce apoptosis (Lomo et al., 
1995). However, in epithelial malignancies the cells may become insensitive to TGF-β 
inhibitory effects what leads to an increase of the cell number and tumor progression (Berg 
and Lynch, 1991; Tada et al., 1991; Kadin et al., 1994; DeCoteau et al, 1997). Among its 
numerous functions, the TGF-β blocks also activated lymphocyte proliferation and has been 
thus suggested to serve as a negative feedback mechanism to reverse the inflammatory 
response (Wahl et al., 1988). It was also demonstrated that the TGF-β1 deletion leads to 
autoimmune disease. It indicates a substantial role of TGF-β in self-tolerance of the immune 
system. It is likely to contribute in negative selection of T cells in thymus. Deletion of TGF-
β leads to imbalanced production of CD4+CD8+ double positive cells due to defective 
apoptosis of differentiating T cells (Letterio and Roberts, 1998). 
Lymphocytes composing the immune system develop from mesodermal 
hematopoietic cells. Our preliminary data demonstrate that Pelo∆/-CreERT ES cells fail to 
differentiate into mesoderm. In parallel, the phenotype of Pelo∆/-CreERT mice indicates an 
immune system disorder, in which the number of mature B and T cells is highly diminished 
due to arrest in T cell differentiation in the thymus, and immature thymocytes are increased 
in number. In case of B cells, it is neccessary to evaluate the number of B cell precursors in 
a cell population of bone marrow, where the differentiation starts, to confirm that 
proliferation is not affected. However, the immune system functionality is impaired and 
inflammation observed in different organs of the mutant mice seems to be the consequence 
of the immune system malfunction. In accordance with our hypothesis, that pelota is 
functionally correlated with TGF-β signalling and mesoderm formation. The mouse 
phenotype, observed upon Pelo inactivation, is prominent in the immune system due to the 
constant differentiation process occuring in hematopoietic cells. However, the bone marrow 
is not the only source of pluripotent cells in the adult mouse. The cell fate shift from 













Figure 48. The scheme presenting putative PELO involvment in TGF-β signalling during 
differentiation process. 
TGF beta 1 activates CDK2AP1 expression. CDK2AP1 joins the NuRD complex, which is 
responsible for Oct4 promoter methylation and in consequence its inactivation. BMP2, a 
TGF-β family member, inhibits STAT3 pathway, which participates in pluripotency 
maintenance. In undifferentiated ES cells STAT3 activ tes c-myc, a proliferation propagator, 
which inhibits TGF-β pathway. PELO/CDK2AP1 may play as a positive feedback regulator 
in TGF-β signalling. According to an alternative hypothesis, PELO positively regulates 






4.4. Pelota in germ cell differentiation 
 
 The testis-specific Pelota knockout mouse (chapter 3.1.6.) demonstrated that 
spermatogenesis is arrested at the spermatocyte stag during its first wave. Deletion of 
floxed Pelo region occurs in accordance with Stra8 promoter which derives Cre recombinase 
expression. As it was reported (Menke et al., 2003; Baltus et al., 2006; Zhou et al., 2008), 
Stra8 gene is active in premeiotic stages of germ cells either in male or female. However, 
the highest protein level is present with onset of meiosis in gonads (Fig. 49). 
 
 
Figure 49. Stra8 expression in developing ovaries and testes (adopted from Zhou et al, 
2008) 
Constant line represents ovaries and doted line – testes mRNA expression during 
embryogenesis (A). Raw signal values are shown on the y axis, days postcoitum – on the x 
axis (A); postnatal Stra8 mRNA expression is presented in B. Raw signal values are shown 
on the y axis, days postpartum – on the x axis (B). 
 
In ovaries, meiosis commences at prenatal stage E14.5, whereas in males it occurs at 
day 10 of postnatal development. The highest level of Stra8 expression coincides with the 
onset of meiosis. The Stra8 expression is thereafter undetectable in ovary, and in testis it 
decreases to a low level, which is comparable to the state of postnatal day 5, when only 
premeiotic germ cells are present in the testis (Zhou et al., 2008). It is worth noting that this 
extreme increase of Stra8 protein happens only during the first wave of spermatogenesis 
(Fig. 49). It indicates that a Stra8-Cre is expressed in the same pattern and the most efficient 
pelota recombination coincides with this event at dy 10 only in the first wave of sperm 
differentiation. It would explain the phenomenon of fertile PeloF/-Stra8-Cre mice. Namely, 
Stra8 protein was demonstrated in different types of germ cells – type A and B 
spermatogonia, preleptotene and early leptotene spermatocytes (Zhou et al., 2008), what 
DISSCUSSION 
 106 
suggests that  the Stra8 promoter is activated later than in germ stem cells (GSCs). It means 
that in all next generations of spermatogonia, the recombination of floxed region will occur 
de novo and due to low expression of Stra8-Cre recombinase, Pelo is excised less 
sufficiently. Therefore, some amount of sperm is successfully produced and mice stay fertile 
(Table 3., chapter 3.1.6.5.). Moreover, Zhou et al. (2008) demonstrated that retinoic acid 
(RA) is critical for Stra8 expression (Koubova et al., 2006) what let us speculate that Stra8-
Cre recombination is variable and RA-dependent. Nonetheless, one can conclude that PELO 
plays a role in meiosis progression, what is convergent with experiments performed in yeast 
and Drosophila (Eberhart and Wasserman, 1995; Davis and Engebrecht, 1998). 
The quantitative analysis of premeiotic markers revealed that expression of Stra8, 
Dazl and Ddx4 in 10-day-old testes is similar – all three markers exhibit a drastic increase of 
transcript level at that time in the control, but in mutant testes we could observe twofold 
reduction (Fig. 25, 26, chapter 3.1.6.4.). In case of Plzf, Sox3 and c-Kit, there is no dramatic 
discrepancy between the control and the mutant, despite the slight reduction at day 5. It 
indicates that there is no clear effect of Pelo depletion at the stage of either undifferentiated 
(Plzf and Sox3) or differentiated (c-Kit) spermatogonia. It suggests that the phenotype 
appears with the onset of spermatogonial differentiation, that is with entry into meiotic 
division. 
However, the question arises whether pelota has any impact on mitotic divisions, i.e. 
GSC self-renewal, as it was reported in Drosophila (Xi et al., 2005). The Stra8-Cre line is 
insufficient model to shed light on this issue. Therefore, we used CreERT-mediated Pelota 
deletion. Tamoxifen-induced recombination occurs independently from developmental stage 
of cells, what makes possible to affect GSCs and all their derivatives during ever-lasting 
spermatogenesis – not only its first wave. 
15-day-old males were treated with tamoxifen. Histological analysis of their testes 
was performed 2 months later. During this period, first wave of spermatogenesis is finished 
and following waves take place. We found complete lack of germ cells, only Sertoli cells 
could be observed in seminiferous tubules of mutant testes (Fig. 33, chapter 3.1.7.2.). The 
phenotype resembles W/WV mutant testes, where no germ cells are present, but some 
spermatogonia could be found. The fact worth mentioning is that W/WV mutant 
spermatogonia are capable of proliferating, but their differentiation abilities are defective 
(Ohta et al., 2003). Our findings suggests that Pelota has also an impact on GSC 
differentiation and mitotic division is not affected.  The phenotype of mutant testis confirms 
our hypothesis concerning an involvment  of pelota in the cell fate shift. As far as TGF-β 
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pathway is concerned, it was demonstrated that Smad proteins, which are mediators in TGF-
β signalling, are upregulated in meiotic germ cells of the rat testis. It was suggested that 
TGF-β may play a putative role in maturation of the first wave of spermatogenesis (Xu et al., 
2003). 
 
4.5. miRNA in pluripotent stem cells during differentiation 
 
 MicroRNA is a family of small (~22 nucleotides) non-coding RNAs, which are 
involved in regulation of gene expression by either d gradation of target mRNA transcripts 
or by disruption of mRNA translation (Kloosterman et Plasterk, 2006). However, it is 
known that there is a group of miRNAs, the members of miR-290 cluster, which are 
abundant in embryonic stem cells, but they become sil nced upon the onset of 
differentiation (Houbaviy et al., 2003, 2005). Zovoilis et al. (2009) showed that miR-290 
cluster inhibits ES cell differentiation process towards mesoderm through negative 
regulation of Wnt pathway. In Pelo∆/-CreERT cells, which fail to form mesoderm, we 
observed upregulation of the miR-290 cluster, what is consistent with the results published 
by Zovoilis et al. (2009). However, after repeating the experiment, we did not obtain any 
increase in miR-290 expression (data not shown). Our data require further investigation to 
evaluate the putative miR-290 upregulation in our system. The question arises, whether this 
upregulation effect is directly related to PELO function or it is rather convergent result of 
balance impairment in the complex signalling network responsible for mesoderm formation 
in the cell. 
 
4.6. Future perspectives 
 
 The aim of this work was to analyze pelota function n self-renewal/differentiation 
processes. The generated conditional knockout system allowed us to reach the goal. We 
demonstrated that pelota is involved in cell fate shift to mesoderm formation from 
pluripotent cells. However, the collected data do not give detailed answers about molecular 
function of PELO protein. Therefore, it would be of great value to analyze mutant ES cells, 
which are subjected to mesoderm formation conditions a d to study the STAT3 level as well 
as TGF-β signalling in NuRD complex activation.  To estimate the approximal stage in 
mesodermal pathway which is disrupted upon PELO depletion, it is important to analyze the 
mRNA levels of lineage-specific markers in embryoid bodies of different age. Further 
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investigation is also neccessary for analysis of hematopoietic cells to confirm the 
differentiation failure and unaffected proliferation in pelota mutant mice. 
To further investigate the differentiation potential of these cells, control and mutant 
ES cell lines were injected into blastocysts and transferred to pseudopregnant mice. The 
generated chimeras will help us to verify the contribution of mutant ES cells in embryonic 
development. Tissues of chimeras, derived from all three germ layers, will be genotyped. 
An alternative way to confirm the potential of Pelo∆/-CreERT ES cells to differentiate, 
is generation of teratoma in immune-deficient (SCID) mice. Histological analysis of 
teratoma will help us to determine abilities of mutant cells to differentiate into different 




























In this work we analyzed the role of pelota in the conditional knockout mouse 
model. We shed light on its function during development and report the defects resulting 
from Pelota depletion. We demonstrated that recombination of floxed Pelo allele was 
complete in ESC system and sufficiently efficient to s udy PELO depletion in mouse.  
We successfully generated a Pelo∆/-CreERT ES cell line. It did not exhibit any 
proliferation disorder, but the cells were defective in differentiation capacities. They 
sustained Oct4 expression, and miR-290 cluster specific for pluripotent cells seemed to be 
upregulated under differentiation conditions. The ectoderm formation was not affected, but 
analysis of early and late markers, specific for mesoderm and endoderm revealed that both 
lineages are not formed in the mutant cells. To confirm the hypothesis, we studied 
differentiation capacities of adult stem cells, i.e. hematopoietic stem cells and 
spermatogonial stem cells. 
Analysis of spermatogenesis revealed that all developmental stages of germ cells 
are absent. For more comprehensive studies, we generat d testis-specific Pelo∆/-Stra8-Cre 
mice, which let us follow the effect of PELO deletion on spermatogenesis progression. The 
analysis of the testes showed arrest in spermatogenic progression during the onset of 
meiotic division (day 15). In 10-day-old testes we d tected a decrease in expression of 
Stra8, Dazl and Ddx4, which are markers for premeiotic stages of germ cells. However, we 
could not find any PELO deletion effect on the leve of either undifferentiated (Plzf and 
Sox3 markers) or differentiated (c-Kit marker) spermatogonia. This suggests that pelota 
exerts the effect on entry into meiosis, that is the beginning of germ cell differentiation. 
Unexpectedly, we also found mosaic mice with partially deleted Pelo allele (PeloF/∆/-Stra8-
Cre) in different somatic tissues, including kidney, liver, heart, spleen, lungs, what 
indicates Stra8 expression in early embryogenesis.  
The studies of mature B and T cells isolated from spleen and thymus of mutant 
mice revealed the reduction in cell number. Additionally, we detected strong increase of 
double negative cells (CD4-CD8-), which are developmental precursors of T cells. 
Simultanously, we observed a dramatic decrease in the level of all later developmental 
stages of T cells. All these data confirm the failure in differentiation abilities of mutant 
cells. 
Adham et al. (2003) studied pelota function in the P lo knockout mouse. The 
phenotype of homozygous mutants (Pelo-/-) was lethal during early stages of 
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embryogenesis. To confirm that this phenotype results from pelota inactivation, we crossed 
Pelo+/- mice with transgenic PeloT mice, which rescued the lethal phenotype. This clearly 
demonstrates the direct relation between lethality nd Pelo depletion. 
The transgenic mice overexpressiong PELO in testis-specific manner did not show 
any phenotype. The mice were fertile and histological analysis demonstrated that 
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